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Summary 1 
1. Summary 
The chaperonin GroEL and GroES form a nano-cage for proteins up to ~60 kDa to fold 
in isolation. The GroEL and GroES system has been thought of as an important but passive 
player in protein folding, providing an encapsulated and isolated environment that allows 
folding to proceed without impaired by aggregation. However, recent experiments showed 
that the folding of bacterial ribulose-bisphosphate carboxylase (RuBisCo) is accelerated in 
the GroEL/GroES folding cage, providing the first hint that the GroEL/GroES cavity could 
be more than just a passive folding container. 
Here we explored the structural features of the chaperonin cage critical for modulating 
the folding of encapsulated substrates. We performed a series of experiments in which the 
volume and surface properties of the GroEL central cavity were altered, and the effects on 
the folding rate and yield of substrate proteins were measured. The substrate proteins of 
different molecular size selected for this study included the small (33 kDa) proteins 
rhodanese and MetF (33 kDa), 41 kDa maltose binding protein (MBP) and the larger, 50 
kDa bacterial RuBisCo.  
By deleting the GroEL C-terminal GGM repeats (13 amino acids) or replicating them 
two, three, or four times, the volume of the GroEL/GroES cis cavity was changed by -13% 
to +4%. Interestingly, modulating the volume of the GroEL cavity affected folding speed in 
accordance with confinement theory. For relatively small proteins of ~30 kDa, rhodanese 
and MetF, reducing cavity size first increased the rate of folding until a critical size limit, 
which, once exceeded, led to a significant decrease in folding rate.  For the larger proteins of 
~40-50 kDa, MBP and RuBisCo, either expanding or reducing the cis-cage volume 
decelerated folding.  
The GroEL/GroES cis cavity wall exposes 189 negatively and 147 positively charged 
residues with a net negative charge of 42. This suggested that electrostatic interactions may 
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also influence the folding rate. By substituting one or more of the negative charged residues 
in each GroEL subunit with Asn, Gln, or Lys, we determined the importance of the charges 
on the folding of the model substrates. Strikingly, for many substrates either the refolding 
yields were reduced or folding rates were affected.  The results revealed that the cis-cavity 
lining can have a profound influence on folding in general.   
We suggest that the GroEL/GroES cage has a tripartite in folding by combining the 
following features: (1) encapsulation offers a safe environment for folding unimpaired by 
aggregation; (2) cavity volume presents a confinement effect which can speed up folding for 
some proteins; (3) by combining negatively charged wall properties with a mildly 
hydrophobic surface, the cage can facilitate rearrangement steps during folding. These 
properties allow GroEL to assist the folding of a wide range of cytosolic proteins.   
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2. Introduction 
Proteins perform most biological processes in cells. Proteins not only provide the 
structural blocks (molecules of the cytoskeleton, epidermal keratin, viral coat proteins) to 
maintain the cell shape, but also execute nearly all cell functions. For instance, catalytic 
proteins (enzymes) mediate biochemical reactions, regulatory proteins (many hormones, 
receptors, kinases, phosphatases and DNA binding proteins) control cellular signal 
transduction and gene expression, transport proteins (hemoblobin, myoglobin, ferritin) 
deliver small molecules or ions to target cells, membrane proteins (channels and pumps) 
regulate the passage of  molecules in and out of cells, and the immunoglobulin superfamily 
of proteins (antibodies and proteins involved in cell-cell recognition) dominate the immune 
system and signaling. To fulfill these biological activities, proteins must adopt precise three-
dimensional structures. The process for acquiring the unique native structure of a 
polypeptide is called protein folding. 
 
2.1. Protein folding 
2.1.1. Protein structure 
Structurally, proteins are polymers of amino acids, joined together by peptide bonds in a 
polypeptide chain. The amino acid sequence of a polypeptide chain is called its primary 
structure. Different regions of the sequence form local regular secondary structure, such as 
α-helices or β-sheets. The tertiary structure is formed by packing such secondary structure 
elements into one or several compact globular units called domains. As many proteins may 
contain several polypeptide chains, a protein’s quaternary structure refers to the spatial 
arrangement of its subunits.   
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In the primary structure, the α carbons of adjacent amino acid residues are separated by 
three covalent bonds, arranged as Cα – C – N – Cα (Figure 1). The six atoms of the peptide 
group lie in a single plane, with the oxygen atom of the carboxyl group and the hydrogen of 
the amide nitrogen group. The peptide C – N bonds are unable to rotate freely because of 
their partial double bond character.  Rotation is allowed of the N – Cα and Cα – C bonds.  
The bond angle resulting from rotations at Cα is labeled φ (phi) for the N – Cα bond and ψ 
(psi) for the Cα – C bond (Figure 1). In principle, φ and ψ can have any angle between -180o 
and 180o, but many angles are excluded by steric interference between atoms in the 
polypeptide backbone and amino acid side chains. G. N. Ramachandran calculated the 
energy contained in various pairs of ψ and φ angles and found two most stable pairs, the so 
called α and β conformations (Ramachandran and Sasisekharan, 1968). These two pairs of 
angles are found to almost exclusively occur in folded proteins, including the two most 
prominent examples of secondary structure: α-helix and β-strand. 
 
 
Figure 1. Rotation about bonds in a polypeptide chain  
Three bonds separate sequential α carbons in a polypeptide chain. The N – Cα and Cα – C 
bonds can rotate, with bond angles designated φ and ψ, respectively. The peptide C – N is 
not free to rotate. Other signal bonds in the backbone may also be rotationally hindered, 
depending on the size and charge of the R groups.  The peptide bond is planar as represent 
in blue shading. Adapted from (Lehninger et al., 2000).  
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In spite of the conformational uniqueness of a protein, the secondary structural elements 
are simple, consisting of helices, sheets and turns. The α-helix and the β-sheet elements 
keep the main chain in an unstrained conformation, and allow hydrogen-bonding potential 
of the main-chain N-H and C=O groups. The α-helical structure was first described in 1951 
by Pauling and Corey (Pauling and Corey, 1951a). In this structure the polypeptide 
backbone is tightly wound around a middle axis, and the R groups of amino acid residues 
protrude outward from the helical backbone. The first α-helix was described in the protein 
α-keratin, which is an abundant protein of the skin and its derivatives are found in hair, nails 
and horns (Pauling and Corey, 1951a). More generally, about one-fourth of all amino acid 
residues on polypeptides are found in α-helices. Pauling and Corey also predicted a second 
type of repetitive structural element, the β-sheet (Pauling and Corey, 1951b), which poses a 
more extensive conformation of a polypeptide chain. In the β-conformation, the polypeptide 
backbone is extended into a zigzag rather than a helical structure. The zigzag polypeptide 
chains can be arranged side by side as was typically found in the protein fibroin, the major 
constituent of silk (Pauling and Corey, 1951b). These two patterns are particularly common 
because they result from hydrogen bonding between the N-H and C=O groups in the 
polypeptide backbone, without involving the side chains of the amino acids. Thus, they can 
be formed by many different amino acid sequences. In each case, the protein chain adopts a 
regular, repeating conformation. 
 
2.1.2. The complexity of protein folding  
How does a polypeptide chain reach its native conformation? Pioneering experiments on 
protein folding were performed in the late 1950s by Christian Anfinsen. Purified, denatured 
Ribonuclease A was shown to fold spontaneously to its native state in vitro upon removal of  
the denaturant, as measured by regain of enzymatic activity (Anfinsen, 1973; Anfinsen et 
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al., 1955). These experiments demonstrated that the amino acid sequence of a polypeptide 
chain contains all the information required to fold the protein into its native, three-
dimensional structure (Anfinsen, 1973).   
Assuming the spontaneous folding process is a random process in which a polypeptide 
chain tries out all possible conformations around every single peptide bond until it 
eventually finds its native form, plus considering that each amino acid residues could on 
average have 10 different conformations, a protein containing 100 amino acid residues 
would result in 10100 different possible conformations. Since the interconversion between 
conformations needs ~10-13 seconds, the 100-residue polypeptide would take about ~ 1077 
years (10100 x 10-13 s = 1087 s) to explore its conformational space. This is far beyond the 
time range of any biological process. In fact, proteins are assembled from amino acids at a 
very fast rate within cells. For instance, E. coil can produce a functional active protein 
containing 100 amino acid residues in about 5 second at 37oC. Thus protein folding cannot 
be a random, trial and error process. This argument was first made by Cyrus Levinthal in 
1968, called Levinthal’s paradox. Levinthal concluded that proteins must fold to their native 
conformation by specific folding pathways (Levinthal, 1968).  The efficient folding must 
proceed through specific transient intermediates, in which local folded elements are 
stabilized to determine further folding of the polypeptide (Baldwin, 1996; Baldwin and 
Rose, 1999; Levinthal, 1968). These intermediates would significantly reduce the number of 
possible conformations during folding and thus allow protein folding to take place on a 
biologically relevant time scale.    
 
2.1.3. Protein folding mechanism 
How does a protein find the right pathway and aviod misfolding or aggregation? 
Serveral plausible models for the mechanism of folding have been proposed (Figure 2). One 
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model, the hydrophobic collapse model, suggests that a protein buries its hydrophobic side 
chains from solvent water, forming a collapsed intermediate or molten globule species,  
from which the native state develops by searching within this conformational state (Baldwin, 
1989; Schellman, 1955). The framework model, on the other hand,  suggests that local 
elements of secondary structure form first and then dock into the native tertiary structure of 
the protein (Kim and Baldwin, 1982; Shoemaker et al., 1985). By contrast, the nucleation 
growth model proposes that the amino acid residues adjacent in sequence form a nucleus 
from which the native structure then develops in a sequential manner. Lastly, the jigsaw 
model suggests that each protein molecule could fold by a different path (Kim and Baldwin, 
1982).  
 
 
 
Figure 2. Plausible models for mechanisms of folding  
At least four models were proposed to tackle the mechanisms of folding after Anfinsen’s 
refolding work. As shown as molten globules/ hydrophobic collapse model, framework 
model, nucleation growth model and jigsaw model. The red arrows indicate β-sheet 
structure and the yellow cylinders represent α-helix.  Adapted from (Radford, 2000). 
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Currently available evidences suggest that most proteins fold via a process that 
incorporates more than one of the models at the same time. Instead of following a single 
pathway, a population of polypeptide chains can take a variety of routes to the native state. 
The folding trajectory can be described in a three- or multi-dimensional energy landscape or 
folding funnel as shown in Figure 3 (Radford, 2000; Schultz, 2000).   
 
 
 
 
Figure 3. Scheme of the folding energy landscape 
The multiple states of the unfolded protein located at the top of the folding funnel might fold 
to the native state by many of different routes. Most of these states represent transient 
intermediates in the folding process. Some of these intermediates retain a stable structure 
such as the molten globule, whereas others may fall into a kinetic trap resulting in the 
formation of misfolded proteins. For proteins that fold without populating intermediates, the 
surface of the funnel would be smooth. Adapted from Schultz, (2000) and Radford, (2000).  
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The energy landscape of folding is represented by a rough surface. Each point on the 
energy landscape presents a conformation of the polypeptide and the corresponding energy. 
The native state of a protein, defined as the conformation with the lowest free energy, is thus 
at the lowest point of the energy landscape or the bottom of the folding funnel. The multiple 
unfolded states are characterized by high conformational entropy and relative high free 
energy. Along the folding process, the protein follows a route from the rim of the funnel to 
the bottom of funnel. Populated intermediates on the way from unfolded to the native state 
are local minima in the energy landscape (Radford, 2000; Schultz, 2000; Troullier et al., 
2000). If the folding intermediate cannot escape a local minimum, it becomes kinetically 
trapped and results in the so-called misfolded protein. 
 
2.1.4. Methods for studying protein folding  
Major advances have been made in illuminating the folding mechanism of proteins 
since the original models described above. These have been derived from a wealth of new 
and elegant experimental approaches (Table 1), combined with theoretical methods.  The 
key to discerning the nature of folding mechanisms is to combine the results from different 
techniques so that different aspects of folding can be probed and the results combined into a 
common picture of the folding process (Dobson et al., 1994). Experimental methods 
commonly used include circular dichroism and fluorescence (Goldbeck et al., 1997), which 
provide information about the extent of secondary and tertiary structure formation. When 
combined with stop-flow methods, they can measure folding events on the millisecond 
timescale (Radford, 2000).  
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 Table 1. Experimental approaches to investigate protein folding  
Technique Time scale  Structural parameter probed 
Fluorescence ns-s  
1. Intrinsic fluorescence  Environment of Trp and Tyr 
2. ANS binding  Exposure of hydrophobic surface area 
3. Substrate binding  Formation of active site 
4. FRET  Inter-residue distance 
5. Anisotropy  Correlation time 
Circular dichroism  ns-s  
1. Far UV  Secondary structure formation 
2. Near UV  Tertiary structure formation 
Small-angle X-ray scattering  ≥ ms Dimension and sharp of polypeptide 
Absorbance (near UV) ns-s Environment of aromatic residues 
FTIR ns-s Secondary structure formation 
NMR   
1. Real time ms-s Environment of individual residues 
2. Dynamic NMR 250 μs Lineshape analysis provides folding-
unfolding rate close to equilibrium  
Hydrogen exchange (HX)   
1. Native state min-months Global stability and metastable states 
2. Plused HX ESI MS ms-s Folding population 
3. Plused HX NMR ms-s Hydrogen-bond formation in specific 
residues 
Atomic force spectroscopy (AFM) s Unfolding forces and rate constants of 
single molecules 
 
The table was modified from Brockwell, (2000) and Radford, (2000). 
Abbreviations: ANS: 1-anilino napthalene sulphonic caid; ESI MS: elctrospray ionization mass 
spectrometry; FRET: fluorescence resonance energy transfer; FITR: fourier transform intra-red.   
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Information about folding at the level of individual residues can be obtained using 
hydrogen exchange (Englander, 2000) and protein engineering. Hydrogen exchange, when 
combined with detection by multidimensional NMR, can be used to determine the location 
and stability of individual hydrogen bonds at different stages of folding. Protein engineering, 
by contrast, provides site-specific information about the role of individual side chains in 
stabilizing populated intermediates and transient high-energy transition states.  In this 
approach, an amino acid side chain is removed from the protein of interest and the effect 
(e.g. by mutating Val to Ala) of the mutation on the stability of the native protein 
(determined by equilibrium denaturation) and the intermediate or transition state 
(determining using kinetics) are measured and compared. The ratio of these stabilities is 
known as a Φ value. By determining many Φ values for residues spread through the native 
protein, the structure of intermediates (if they are populated) and the rate-limiting transition 
state can then be inferred (Fersht et al., 1992).  
A major developing area in folding is the establishment of techniques that can monitor 
the process on sub-millisecond timescales, so that important early events can be monitored 
(Brockwell et al., 2000) (Table 1). Such methods include ultra-rapid mixing, temperature 
jump and pressure jump experiments (Eaton et al., 2000; Roder and Shastry, 1999). When 
combined with detection methods such as fluorescence or circular dichroism, these can 
access folding events occurring on very fast timescales (nanosecond to microsecond). In 
parallel to these advances, a number of theoretical methods have been developed to simulate 
protein folding. These include molecular dynamics that can be used to monitor the unfolding 
of proteins at atomic resolution (usually at very high temperatures to speed up the process) 
and the folding of small proteins for up to milliseconds using the computer power that is 
now available (Duan and Kollman, 1998). In contrast, lattice simulations rely on very 
simple models for proteins based on polymer beads but have the advantage that the 
conformational space can be searched exhaustively (Dinner et al., 2000).  Together, these 
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approaches have provided new insights into the folding and unfolding processes of several 
proteins and agree well with experimental results (Brockwell et al., 2000). 
    
2.2. Protein folding in the cell 
Although the protein folding mechanism has been extensively studied in vitro (Dobson 
and Karplus, 1999), folding of polypeptides in the cellular environment is much more 
complex, since the in vivo environment is extremely crowded and dynamic in comparison to 
the conditions of in vitro refolding.  
 
2.2.1. Highly crowded milieu in the cell  
The effective protein concentration in E. coli cells has been estimated to be as high as 
300 to 400 mg/ml (Ellis, 2001a; Zimmerman and Minton, 1993) (Figure 4). Because of high 
concentration of proteins, nucleic acids and others macromolecules, the cytoplasm no longer 
serves as an ideal place for polypeptides to fold. Besides, this crowded environment gives 
rise to excluded volume effects, which can result in a significant increase in the affinities 
between interacting macromolecules by up to 10-100 fold (Minton, 2000; van den Berg et 
al., 1999).  As a consequence, the intermolecular binding constants between partially folded 
states are increased, leading to an increased probability of aggregation during folding (van 
den Berg et al., 1999).  
Another major difference between in vitro refolding and de novo folding is that folding 
in the cell must be accomplished in the context of the vectorial synthesis of polypeptide 
chains on ribosomes. The formation of a stable tertiary structure requires a complete protein 
domain sequence (usually 50 to 300 amino acid residues in length), and the unavailability of  
the C-terminal residues of a translating polypeptide within the ribosomal channel results in  
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prolonging the time for hydrophobic residues of a polypeptide to be exposed (Jaenicke, 
1991). Nascent chains must therefore avoid forming misfolded intermediates and avoid 
aggregation with other nascent chains. Since translation occurs on polyribosomes, nascent 
chains may be especially prone to undergo inter-molecular clustering (Ellis and Hartl, 
1999).  
 
Figure 4. The crowded state of the cytoplasm 
(A) Eukaryotic and (B) E. coli cells. Each square illustrates the face of a cube of cytoplasm 
with an edge 100 nm in length. The sizes, shapes and numbers of macromolecules are in the 
order of actual cytosolic concentration. Small molecules are not shown. Adapted from Ellis 
(2001). 
 
Misfolding and aggregation in the cell leads not only to inactivation of the affected 
proteins, but can result in severe cellular dysfunction, causing a number of human diseases 
(Barral et al., 2004). Protein misfolding diseases can be divided into two groups: in the first, 
diseases in caused by excessive amounts of misfolded proteins aggregating into the form of 
fibrils. A well known disease of amyloidoses is Alzheimer’s disease (Dobson, 2003).  One 
of the main characters of Alzheimer’s disease is the accumulation of insoluble β-amyloid in 
the brain. The second group of protein misfolding diseases are those caused by smaller 
errors (point mutations) in the genetic blueprint leading to incomplete folding of a protein, 
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which affects its function. For instance, there are several point mutations found to constraint 
the folding of p53 with high correlation in association with different cancers, such as R249S 
in hepatocellular carcinoma as one of the most prominent case (Hsu et al., 1991).   
Over the past two decades, a group of molecules have been identified that assist non-
native proteins in folding under cellular conditions. This group of molecules is referred to as 
molecular chaperones (Martin and Hartl, 1993). Molecular chaperones interact with non-
native polypeptides and prevent their misfolding and aggregation. They contribute towards 
successful folding to the native structure without providing specific conformational 
information to the folding process, in agreement with the conclusion reached by Anfinsen 
that the tertiary structure of a protein is solely determined by its own amino acid sequence 
(Anfinsen, 1973).  
 
2.3. Molecular chaperone systems  
In order to assist many diverse types of proteins to fold in living cells, molecular 
chaperones have evolved to perform versatile tasks by cooperating with each other (Young 
et al., 2004). In both prokaryotic and eukaryotic cells, the cytosol provides a well-developed 
network of chaperone pathways that help polypeptides from translation to the folded 
protein.  
 
2.3.1. The chaperone network in the cytosol  
As summarized in Figure 5 (Hartl and Hayer-Hartl, 2002), all three kingdoms of life are 
equipped with molecular chaperones for efficient protein folding. All nascent chains 
presumably interact with ribosome-associated chaperones. Small polypeptides chains (~65 
to 80% of total) probably fold rapidly upon releasing from these chaperones. Longer nascent 
chains (10 to 20% of total) interact subsequently with Hsp70/Hsp40 system which assists 
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folding through ATP-dependent binding and release. About 10 to 15% of proteins which fail 
to fold with the upstream chaperones are further transferred to the chaperonin system which 
provides a sequestered environment for protein folding.     
    
 
 
 
Figure 5. Models for the chaperone-assisted folding of de novo polypeptides  
(A) In eubacteria, nascent chains probably first interact with trigger factor (TF), and most 
small proteins (~65 to 80%) fold to their native protein (N) without further chaperone 
interaction. Longer chains (10 to 20%) interact consequently with the DnaK/DnaJ/GrpE 
system and fold upon the ATP-dependent binding and release. About 10 to 15% of chains 
transit the chaperonin system (GroEL and GroES) for folding after their interaction with 
DnaK. (B) In archaea. Only some species contain DnaK/DnaJ. Interaction of prefoldin 
(PFD) with nascent chains and existence of nascent chain-associated complex (NAC) are 
not experimentally confirmed. (C) In eukarya, NAC probably interacts with nascent chains 
similar to TF in bacteria. The majority of small chains may fold upon release from 
ribosome. About 15 to 20% of chains reach their native states by Hsp70 and Hsp40. A 
subset of Hsp70 substrates needs further assistances by the Hsp90. About 10% of chains are 
co- or post-translationally passed on to the chaperonin TRiC in a reaction mediated by PFD. 
From Hartl and Hayer-Hartl (2002).  
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2.3.2. Ribosome–associated chaperones     
Nascent chains emerging from the ribosomal exit tunnel are generally awaited by 
ribosome-associated chaperones, such as trigger factor (TF) in bacteria and nascent chain-
associated complex (NAC) in eukaryotes (Figure 5) (Hartl and Hayer-Hartl, 2002).  
In E. coli, TF was found to interact with most nascent chains by a cross-linking 
approach (Hesterkamp et al., 1996). TF is a 48 kDa protein, which binds at a 1:1 
stoichiometry to the large subunit of the ribosome (Hesterkamp et al., 1996). TF docks 
specifically through separate domain onto the ribosomal L23 protein and also contacts the 
ribosomal protein L29. Although TF has peptidyl-prolyl cis/trans isomerase (PPIase) 
activity, the significance of PPIase activity of TF remains unclear (Genevaux et al., 2004; 
Kramer et al., 2004). Notably, TF is an ATP-independent chaperone, it does not assist 
folding in a nucleotide-regulated manner. TF is thought to function by scanning nascent 
chains and shielding hydrophobic regions to keep them from misfolding or aggregating.  
In eukaryotes, the cytosol contains instead of TF a ribosome-associated heterodimeric 
complex of α (33 kDa) and β (22 kDa) subunits, called NAC (Shi et al., 1995; Wiedmann et 
al., 1994). NAC was shown to bind ribosomes and interact with nascent chains as they 
emerge from the ribosomal exit tunnel. NAC seems to influence the fidelity of co-
translational targeting of nascent chains to the endoplasmic reticulum (Wiedmann et al., 
1994). The actual function of NAC in protein folding remains to be established. However, 
NAC has no ATPase activity and probably functions by simply binding and protecting 
hydrophobic stretches of nascent chains in a manner similar to TF.  In addition to NAC, the 
eukaryotic model organism Saccharomyces cerevisiae contains another hetero-dimeric 
chaperone, called ribosome-associated complex (RAC), which associates with ribosome 
nascent chain complex (RNC). RAC consists of Ssz1, a member of the Hsp70 family, and 
the DnaJ-related Hsp40 protein zoutin (Gautschi et al., 2001; Gautschi et al., 2002; 
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Michimoto et al., 2000). The J-domain of Zoutin was proposed to interact with Hsp70’s, 
most likely serving as the Hsp40 partner for Ssb1 and Ssb2 (Bukau et al., 2000; Yan et al., 
1998). Mutations in the J-domain of zoutin or deletion of the ssz1 gene, but not the Ssz1 
truncated mutant lacking the putative substrate binding domain, result in the same 
phenotype that is observed upon deletion of the ssb genes, indicating that RAC is required 
for the recruitment of the Ssb proteins to the ribosome (Gautschi et al., 2002; Hundley et al., 
2002). Ssz does not seem to rely on ATPase activity (Huang et al., 2005), therefore it might 
act as a modulator of zoutin rather than as a chaperone itself (Huang et al., 2005). 
  
2.3.3. The Hsp70 system  
The Hsp70 chaperones are monomeric proteins of ~70 kDa in size, composed of a ~45 
kDa amino-terminal ATPase domain and a ~25 kDa carboxyl-terminal polypeptide binding 
domain (Figure 6A). They are found in the cytosol of eubacteria, eukarya and some achaea 
(Figure 5), as well as within eukaryotic organelles, such as mitochondria and endoplasmic 
reticulum.  They have important roles in protein metabolism both under stress and non-
stress conditions, including in de novo protein folding, membrane translocation and the 
degradation of misfolded proteins (Bukau et al., 2006). 
The crystal structures of individual domains of Hsp70s have been solved: the N-
terminal ATPase domain structure of DnaK binding to its nucleotide exchange factor, GrpE 
(Harrison et al., 1997), and a C-terminal domain that binds substrate polypeptides (Figure 6 
A) (Zhu et al., 1996). The substrate-binding domain can be further divided into a β-
sandwich subdomain with a peptide-binding cleft and an α-helical latchlike segment (Zhu et 
al., 1996). Recently, a full length structure of bovine Hsc70 has been determined (Jiang et 
al., 2005), that allows us further understanding of the inter-domain interaction and how the 
ATPase and the substrate cycling proceed for Hsp70. 
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Figure 6. The structure and reaction cycle of the DnaK system 
(A) (Top) Structures of the ATPase domain (Harrison et al., 1997) and the peptide-binding 
domain (Zhu et al., 1996) of DnaK. ATP indicates the nucleotide binding site of ATPase 
domain. The α-helical latch of peptide-binding domain is shown in yellow and the peptide 
substrate in pink. (Bottom) The interaction of prokaryotic and eukaryotic cofactors with 
Hsp70 is shown schematically. The C-terminal EEVD sequence is only present in 
eukaryotic Hsp70s and is involved in binding of TPR motifs. (B) K: DnaK; J: DnaJ; E: 
GrpE, S: substrate peptide. Non-native substrate polypeptides associate with either DnaJ (J) 
or DnaK (K) in the ATP-bound open state. DnaJ and substrate protein stimulate ATP 
hydrolysis of DnaK, leading to closure of its substrate binding pocket. GrpE is required for 
efficient release of ADP from the complex, and subsequent ATP binding results in opening 
of the substrate binding pocket and exchange of substrate polypeptides. The released 
substrate can either fold towards the native state or rebind to DnaJ or DnaK. Adapted from 
Hartl and Hayer-Hartl (2002).    
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The best studied Hsp70 is the E. coli Hsp70, DnaK.  Its reaction cycle is shown in 
Figure 6B. The cochaperone DnaJ (41 kDa) first interacts with an unfolded polypeptide via 
its C-terminal domain, and then targets the polypeptide to DnaK by its N-terminal J domain. 
DnaK binds the polypeptide in the ATP-bound state. The interaction with DnaJ then 
stimulates the hydrolysis of ATP by DnaK and stabilizes its ADP-bound state (Mayer et al., 
2000). In the ATP-bound state, DnaK binds and releases substrates rapidly; the α-helical 
latch over the peptide-binding cleft is in an open conformation (Figure 6B). In contrast, the 
ADP-bound state has slow exchange rate for peptides since the α-helical latch is closed over 
the substrate (Zhu et al., 1996). The nucleotide exchange factor GrpE promotes the release 
of ADP from DnaK, which is rate-limiting in this cycle. The substrate dissociates from 
DnaK upon subsequent ATP binding to DnaK (Schmid et al., 1994) and has the option of 
either folding, rebinding to DnaJ and DnaK or being transferred to another chaperone 
system, such as the chaperonin, for final folding (Figure 5). 
Eukaryotic Hsp70s follow the similar ATPase cycle as DnaK. The DnaJ homologs 
(Hsp40s) also interact with polypeptides and stimulate the ATP hydrolysis of their partner 
Hsp70 proteins (Johnson and Craig, 2001; Lopez et al., 1998). Although the prokaryotic and 
eukaryotic Hsp70 systems have a similar mechanism, a GrpE homolog for nucleotide 
exchange has not been found in the eukaryotic cytosol.  The nucleotide exchange reactions 
for Hsp70s in the eukaryotic cytosol are performed by structurally unrelated proteins, for 
instance, the mammalian co-chaperone BCL2-associated athanogene-1 (Bag1) (Hohfeld and 
Jentsch, 1997) and the mammalian Hsp70-binding protein (HspBP1) and its S. cerevisiae 
homolog Fes1(Kabani et al., 2002a; Kabani et al., 2002b). More recently Hsp110, a distant 
homolog of Hsp70 was found to also serve as a nucleotide exchange factor for Hsp70 
(Dragovic et al., 2006; Raviol et al., 2006). Interestingly, these factors distort the ATPase 
domain to release ADP in different manners and efficiencies, suggesting the nucleotide 
exchange event is a regulatory tactic rather than an acceleration strategy for eukaryotic 
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Hsp70s. A possible explanation could derive from the general feature that eukaryotic 
Hsp70s have slower ATP hydrolysis rates than their prokaryotic counterparts, which implies 
that the rate-limiting step is the ATPase cycle of eukaryotic Hsp70s is not dissociation of 
ADP but the hydrolysis of ATP itself.     
How does Hsp70 recognize unfolded polypeptides? By using phage display and 
synthetic peptide library approaches, Hsp70 was found to recognize linear polypeptide 
sequence enriched in hydrophobic amino acids (Flynn et al., 1991; Rudiger et al., 1997b). 
Because of its hydrophobic nature, this binding motif would typically be located in the 
interior of a folded protein; consequently, surface exposure of such a sequence may be a 
distinctive feature of nonnative conformations. Such hydrophobic regions are probably 
present in all unfolded polypeptides, and it has been predicted that an Hsp70-binding site 
occurs, on average, every 40 residues (Rudiger et al., 1997a). Association with Hsp70 
results in the stabilization of the substrate protein in an extended conformation, thereby 
preventing its aggregation. In vitro, polypeptides can undergo multiple rounds of binding 
and release from Hsp70. This process is sufficient to promote folding of some model 
substrates, such as firefly luciferase (Szabo et al., 1994). However, in many cases, the 
Hsp70-bound substrates must be transferred to the chaperonin system for productive 
folding.    
 Besides ribosome-associated chaperones, Hsp70s are important in chaperoning nascent 
chains. As it has been shown that DnaK preferentially associates with elongating 
polypeptides larger than 20 to 30 kDa, thus DnaK interacts with nascent chains subsequent 
to TF (Teter et al., 1999) (Figure 5A). DnaK has an overlapping chaperone function with 
TF. Upon deletion of TF in E. coli, DnaK can substitute TF function in chaperoning nascent 
chains. However, the deletion of both TF and DnaK at 37oC leads to a severe loss of 
viability, and results in the accumulation of misfolded, aggregated proteins (Agashe et al., 
2004; Teter et al., 1999). Intriguingly, while bacterial proteins efficiently apply TF and 
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DnaK for folding, their actions in concert were found to cause a delay of the folding process 
relative to translation for certain multi-domain proteins. The unexpected working paradigm 
indicates a fundamental difference of folding pathways utilized in bacterial and eukaryotic 
cells to prevent misfolding and aggregation during translation (Agashe et al., 2004). Similar 
to DnaK, mammalian Hsc70 also binds a wide range of nascent chains (> 15% of total), 
including many multi-domain protein >50 kDa (Thulasiraman et al., 1999). In cooperation 
with the Hsp40 homologs Hdj1 and Hdj2, Hsp70s can achieve the co-translational folding of 
polypeptides (Nagata et al., 1998; Terada et al., 1997). In addition, Hsc70 is probably 
recruited to the ribosome by the recently identified human zoutin ortholog Mpp11, which 
illustrates that ribosome-tethered chaperones have been conserved through evolution 
(Hundley et al., 2005).   
 
2.3.4. The chaperonins: Hsp60 and Hsp10  
Chaperonins are a conserved class of large double-ring complex of ~800 kDa with a 
central cavity (Braig et al., 1994; Hartl, 1996). There are two chaperonin subgroups that are 
similar in architecture but distantly related in amino acid sequence. Group I chaperonins, are 
generally found in eubacteria, such as GroEL in E. coli and the Hsp60 in mitochondria and 
chloroplasts. They cooperate with a ring-shaped co-chaperone, GroES or Hsp10, that forms 
the lid on a folding cage in which polypeptide substrates can be encapsulated during folding 
(Mayhew et al., 1996; Weissman et al., 1996). While Group II chaperonins exist in archaea 
and eukarya. They are independent of a co-chaperone but have helical protrusions in the 
apical domains of the chaperonin subunits which function as an inbuilt lid (Ditzel et al., 
1998). 
Bacterial GroEL is the most prominent example of Group I chaperonins (Bukau and 
Horwich, 1998; Hartl, 1996; Hartl and Hayer-Hartl, 2002). GroEL was first identified in the 
early 1970s by Costa Georgopoulos and colleagues; they observed that certain temperature-
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sensitive mutations in the GroE operon were unable to support the growth of bacteriophage 
λ (Georgopoulos et al., 1973). It was subsequently demonstrated by Georgopoulos’s group 
that the two proteins encoded in this operon, GroES and GroEL, are essential for the 
viability of E. coli at all temperatures (Fayet et al., 1989). In 1980s, John Ellis and 
colleagues identified a 60 kDa RuBisCo binding protein (RBP) that transiently associated 
with chloroplast RuBisCo Large-subunits during synthesis (Barraclough and Ellis, 1980) 
and RBP was then recognized as a homolog of GroEL. The in vitro refolding efficiency of 
bacterial RuBisCo was shown to be significantly improved by GroEL and GroES 
(Goloubinoff et al., 1989). Along with these findings, mitochondrial hsp60 was soon found 
to play a role in the folding of proteins imported into mitochondria (Ostermann et al., 1989).  
GroEL contains 14 identical 57-kDa subunits arranged in two stacked rings of seven 
subunits each. And according to its crystal structure, each subunit of GroEL consists of three 
domains; the equatorial domain contains the ATP-binding site and is connected via a hinge-
like intermediate domain to the apical domain (Figure 7) (Braig et al., 1994; Steinbacher 
and Ditzel, 2001; Xu et al., 1997). The equatorial domain contains the ATP-binding sites 
and mediates the most inter-subunit contacts within and between GroEL rings. The small 
intermediate domain has flexible hinge regions at the domain junctions that allow large 
structural rearrangements upon cooperative binding of seven ATP molecules and subsequent 
GroES binding. The apical domain forms the ring opening and exposes a number of 
hydrophobic residues toward the cavity for the binding of a nonnative substrate as well as 
for interacting with GroES (Fenton et al., 1994; Xu et al., 1997), a hepameric dome-shape 
ring of 10-kDa subunits. (Figure 7A) (Hunt et al., 1996).  The details of the GroEL and 
GroES system will be discussed more thoroughly in the next section.  
Group II chaperonins are more heterogeneous in sequence and structure than members 
of Group I (Leroux and Hartl, 2000). Although Group II chaperonins also have a double 
ring structure, they are generally hetero-oligomeric and the number of subunits varies 
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between eight and nine per ring (Figure 7B and 7D). For example, the eukaryotic 
chaperonin, TRiC (TCP-1 ring complex) or CCT (chaperonin containing TCP-1), contains 
eight different subunits per ring, ranging from 50 to 60 kDa (Frydman et al., 1992; Gao et 
al., 1992). On the other hand, the archaeal chaperonin, thermosome, consists of one to three 
different subunits, which are arranged in eight- or nine-fold symmetrical rings. The crystal 
structure of the archaeal thermosome complex revealed that individual subunits have a 
domain arrangement similar to those in GroEL (Ditzel et al., 1998). In contrast to the 
equatorial (ATP-binding) domain which is relatively well conserved among all chaperonins, 
apical domain of Group II chaperonin is highly divergent in sequence from that in GroEL. 
Although the backbone trace of the apical domain of the thermosome is almost identical to 
that of GroEL, an additional α-helical insertion is found to extend as a large protrusion 
toward the central cavity (Klumpp et al., 1997). Since the major difference between Group I 
and Group II chaperonins is the lack of a GroES-like cofactor for Group II chaperonins, this 
protrusion is thought to function as a built-in lid, as well as to be involved in substrate 
binding (Klumpp et al., 1997; Llorca et al., 1999).  
Compared to the Group I chaperonins, the mechanism by which the Group II 
chaperonins mediate protein folding is less understood. The most prominent substrates of 
TRiC are cytoskeletal proteins actin and tubulin. Interestingly, the folding of these proteins 
cannot be mediated by the bacterial homolog, GroEL and GroES. Considering the high 
abundance of actin and tubulin in cells, and only a low concentration of TRiC exist in the 
cytosol, it strongly suggests that TRiC might have a more specific function in folding a 
subset of cytosolic proteins. Additionally, TRiC was shown to interact with nascent 
polypeptides like actin and firefly luciferase, by using a cross-linking approach (McCallum 
et al., 2000), indicating that TRiC may act co- translationally in the folding of proteins that 
are too big to be encapsulated as a whole (Frydman et al., 1994), unlike the post-
translational folding catalyst GroEL. Consistent with that, a pulse-chase analysis in 
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mammalian cells revealed that TRiC interacts transiently with a wide range of newly 
synthesized chains of 30 to 120 kDa in size (Thulasiraman et al., 1999).     
 
Figure 7. Architecture of Group I and II chaperonins.   
 (A) Side view of Group I chaperonin, GroEL/GroES complex in ADP-bound state (Xu et 
al., 1997). The equatorial ATPase domain (red) is linked to the substrate-binding apical 
domain (yellow) by a flexible hinge or intermediate domain (green). GroES is shown in 
dark green. (B) Side view of the T. acidophilium thermosome (Ditzel et al., 1998), color 
coded as in (A). (C) Top view of the cis ring with apical domains in yellow and GroES in 
gray. (D) Top view showing only the apical domain of thermosome. (E) Domain 
arrangements in GroEL: the left panel shows the nucleotide-free state of GroEL and the 
right panel presents that in the ADP-bound state. (F) Domain arrangement in the 
thermosome. Nucleotides are shown as ball models. Modified from (Steinbacher and Ditzel, 
2001).  
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The nascent chain-associated chaperone, prefoldin (PFD), was found to cooperate with 
Group II chaperonins. PFD, also known as the GimC (genes involved in microtubule 
biogenesis complex), is a ~90 kDa complex of two α and four β subunits in the archaeal and 
eukaryotic cytosol (Siegert et al., 2000; Vainberg et al., 1998). Substrates binding and 
release by PFD is ATP independent, and in vitro, mammalian and archaeal PFD can 
stabilize nonnative proteins for subsequent transfer to a chaperonin (Leroux et al., 1999; 
Siegers et al., 1999). The substrate-binding site of PFD overlaps with its chaperonin-binding 
site, suggesting a mechanism for the transfer of PFD-bound substrates to Group II 
chaperonin (Martin-Benito et al., 2002; Okochi et al., 2004). The completion of folding of 
substrates is most likely achieved by Group II chaperonin after the delivery by PFD.  
 
2.4. The E. coli chaperonin system: GroEL and GroES 
2.4.1. Structure and function of GroEL and GroES  
The structure of the GroEL/GroES complex has been extensively studied by electron 
microscopy (Braig et al., 1993; Langer et al., 1992; Saibil et al., 1991) and X-ray 
crystallography (Braig et al., 1994; Xu et al., 1997). Under physiological conditions, one 
GroES heptamer binds to one GroEL tetradecamer, thereby forming an asymmetric 
complex. The GroES bound ring is called cis ring, and the unliganded GroEL ring is called 
trans ring (Figure 8).   
The domain rearrangement of GroEL between nucleotide-free and bound states is 
shown in Figure 9. The dramatic reshaping of the cis ring is due to the intermediate and 
apical domains rearrangements (Figure 9C) (Xu et al., 1997). First, the intermediate domain 
swings down towards the equatorial domain and the central cavity, pivoting approximately 
25o around Pro137 and Gly 410.  This movement locks the nucleotide binding sites and 
generates new interactions with the bound nucleotide and the equatorial domain. Second, the 
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Figure 8. Architecture of GroEL-GroES-(ADP) 7 complex  
Space-filling models of GroEL–GroES–(ADP) 7 with 6 Å Van der Waals spheres around Ca 
atoms.  The cis ring of GroEL is gray and trans ring is blue. GroES is shown in green. The 
left panel is view from outside; the right panel is from the inside, generated by slicing the 
models with a vertical plane that contains the cylindrical axis. Figures are modified from 
Bukau and Horwich, (1998).  
 
 
apical domain swings up 60o and twists around the long axis of the domain about 90o, 
forming new interactions with nearby apical domains and leading to an interaction with the 
mobile loop of GroES. Eventually, the domain rearrangements result in burying 
hydrophobic residues and hence changing the environment inside the GroEL-GroES cavity 
to hydrophilic (Figure 10). In addition the volume of the cavity is approximately enlarged 
by two-fold (Hayer-Hartl et al., 1996; Roseman et al., 1996; Weissman et al., 1994). This 
hydrophilic cage can accommodate single partially folded polypeptides up to ~60 kDa 
(Sigler et al., 1998; Viitanen et al., 1992). 
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Figure 9. The domain movements within individual subunits of the cis GroEL ring  
The upper panels show ribbon diagrams of an individual subunit of unliganded (A) and 
liganded (B) GroEL. The orientation of the representative subunit is the same as the colored 
subunit in the nearby space-filling model. The equatorial, intermediate, and apical domains 
are blue, green, and red, respectively. Note that GroES is only shown in B, to reveal more 
clearly the extent of motion of the apical domain. The nucleotide (ADP) in the right-hand 
structure is a yellow space-filling model. (C) Schematic representation of GroEL showing 
diagrammatically the en bloc movements that occur around the pivot points at the ends of 
the intermediate domain. Domains are colored as in the upper panels, and the small yellow 
circle on the top of the equatorial domain represents the nucleotide. (D) The left panel 
shows a space filling model of a side view of a GroEL-GroES complex. The GroES subunit 
is colored individually. The right panel shows a side view of a single GroES subunit in a 
ribbon drawing. Mobile loop as well as the GroEL interacting loop is indicated. Adapted 
from Xu et al. (1997). 
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Similar to GroEL, GroES forms a heptameric ring of ~10 kDa subunits. Each GroES 
subunit is folded into a single domain, which contains nine β-strands with one exceptionally 
long β-hairpin loop, the so-called mobile loop (Figure 9D). The GroEL-GroES contact is 
mediated through the mobile loop (Landry et al., 1993). This loop contains 16 amino acids 
which appear highly mobile in the uncomplexed GroES but become more structured upon 
interacting with GroEL. Because the hydrophobic binding regions of GroEL for polypeptide 
overlap with those for GroES (Fenton et al., 1994), GroES binding leads to the displacement 
of the bound polypeptide from the apical domains into the central cavity which is then 
permissive for folding (Martin et al., 1993; Weissman et al., 1996).    
 
 
 
Figure 10. Hydrophobic surface at the interior of the GroEL cavity  
An interior view of four subunits from each ring of the asymmetric structure, colored to 
reflect the relative hydrophobicity of the interior surface. Hydrophobic side-chain atoms are 
shown in yellow; polar and charge side-chain atoms are shown in blue. All solvent –
excluded surfaces at the subunit interface are grey; and exposed backbone atoms are white. 
The surface of trans GroEL is considerably more hydrophobic than the surface of cis GroEL.   
From Xu et al. (1997) 
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2.4.2. Substrates of GroEL and GroES  
Almost all unfolded proteins, including some heterologous substrates such as 
mitochondrial malate dehydrogenase, R. rubrum RuBisCo and bovine rhodanese, interact 
with GroEL in vitro (Goloubinoff et al., 1989; Hartman et al., 1993; Martin et al., 1991).  In 
vivo, 10-15 % of cytosolic proteins of E. coli were observed to co-immunoprecipitate with 
GroEL (Ewalt et al., 1997; Houry et al., 1999). A recent extensive proteomic study revealed 
that approximately 250 different proteins of the ~2,400 cytosolic E. coli proteins interact 
with GroEL upon synthesis (Kerner et al., 2005). These newly identified GroEL substrates 
are classified into three classes. Class I proteins are largely independent of chaperone 
interaction but their folding yield can be increased by chaperones. Class II proteins do not 
refold efficiently in the absence of chaperones, but can utilize either the Hsp70 
(DnaK/DnaJ/GrpE) or the GroEL/GroES system for folding. Class III substrates are fully 
dependent on the GroEL/GroES system for folding. The Hsp70 system can bind Class III 
proteins and prevent their aggregation, but folding is only achieved upon transfer to GroEL. 
Of these 250 substrates, ~85 are predicted to be obligate chaperonin substrates (Kerner et 
al., 2005). Importantly, the obligate GroEL substrates include at least 13 essential proteins, 
explaining why the GroEL/GroES system is indispensable for E. coli viability (Fayet et al., 
1989).  
Obligate GroEL substrates are typically 30-50 kDa in size and display complex α/β or 
α+β domain topologies, with (βα) 8 TIM barrel domains being significantly represented 
compared to the fold distribution of total cytosolic proteins (Kerner et al., 2005). These 
proteins appear to rely on GroEL for folding and to avoid or overcome kinetically trapped 
states at a biologically relevant time scale.  
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2.4.3. Mechanisms of GroEL and GroES mediated protein folding 
GroEL and GroES assisted polypeptide folding involves two functional elements: (1) 
prevention of aggregation by binding non-native polypeptides; and (2) release of unfolded 
polypeptides into a sequestered compartment permissive for folding. Although the binding 
of unfolded polypeptide is independent of GroES, GroEL is critically dependent on GroES 
for providing a folding compartment.  GroES cycles on and off either end of GroEL 
cylindrical rings in a manner regulated by the ATPase activity of GroEL. The chaperonin 
reaction begins by the binding of substrate polypeptide to the nucleotide-free state of GroEL 
(trans ring) (Figure 11). ATP and GroES then bind to the same ring, thereby resulting in the 
displacement of substrate into a newly formed cis ring and causing the dissociation of seven 
ADP molecules and GroES from the former cis complex. Upon binding to GroES, the apical 
domains undergo a massive rotation and upward movement (Roseman et al., 1996; Xu et 
al., 1997), generating an enlarged hydrophilic cavity (Figure 10). Nonnative proteins up to ~ 
60 kDa can be encapsulated and are free to fold in the GroEL-GroES cage, the so-called 
Anfinsen cage (Brinker et al., 2001; Ellis, 2001b; Mayhew et al., 1996; Weissman et al., 
1996). Folding is allowed to proceed for ~ 10 s, timed by the hydrolysis of seven ATPs in 
the cis ring. Binding of ATP and GroES to the opposite trans ring triggers the opening of 
the Anfinsen cage. Both native protein and nonnative intermediate exit at this point (Figure 
11), but folding intermediates that still expose extensive hydrophobic surfaces are rapidly 
recaptured and the refolding cycle is repeated until the protein reaches its native state.  
Although there is general agreement on the GroEL cis cycling process, two competing 
models, the “Anfinsen cage” model and the “iterative annealing” model, however, have 
been proposed to address how chaperonins can accelerate protein folding. (Betancourt and 
Thirumalai, 1999; Ellis and Hartl, 1996; Wang and Weissman, 1999).  
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Figure 11. Simplified reaction of protein folding in the GroEL-GroES cavity.  
A folding intermediate (I) binds to the apical domains of the trans ring (green) of GroEL. 
Binding of ATP and GroES (a dome-shape heptamer indicated in blue) displaces this 
polypeptide into the new forming cis cavity (cyan). Folding intermediate is given the chance 
to fold in this sequestered cage during one round of ATP hydrolysis (~10 s). Binding of 
other ATP and GroES to the opposite ring triggers the release of ADP, GroES and 
encapsulated polypeptide in either native (N) or intermediate state. If the polypeptide is still 
in intermediate state, it is then rapidly rebound by GroEL. Adapted from Hartl and Hayer-
Hartl (2002).  
 
The Anfinsen cage model is based on the hypothesis that a folding event is largely 
limited by intermolecular interactions that result in aggregation. This model proposes that 
the GroEL cavity provides a sequestered environment where folding of a substrate protein 
proceeds similar to infinite dilution (Ellis, 1996). 
The iterative annealing model, on the other hand, proposes that the rate-limiting step in 
protein folding is the intramolecular reorganization of misfolded and kinetically trapped 
protein (Sosnick et al., 1994). This model suggests that the energy of ATP hydrolysis is 
used for the forceful unfolding of the misfolded substrate protein (Todd et al., 1996; Todd et 
al., 1994).  Upon release from the apical domain into the bulk solution or the GroEL cavity, 
the actively unfolded substrate protein is then given a chance to fold. Incompletely folded 
proteins undergo further unfolding cycles until the native state is achieved. Since the time of 
encapsulation in the GroEL/GroES complex (~10 s) is relatively short compared to the time 
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required for folding of many GroEL substrates (minutes), this model also suggests that 
folding may continue to proceed outside the chaperonin cage upon release.  
Although the iterative annealing model has been supported by an intriguing hydrogen-
tritium exchange measurement that detected partial unfolding of bacterial ribulose bis-
phosphate carboxylase (RuBisCo) during a single reaction cycle of GroEL (Shtilerman et 
al., 1999), similar unfolding was failed to be detected by NMR analysis of using malate 
dehydrogenase as substrate (Chen et al., 2001), neither with analogous experiment on 
human cyclophilin (Zahn et al., 1994), human DHFR (Gross et al., 1996), and β-lactamase 
(Gervasoni et al., 1998) is displaying such protection and hydrogen exchange. Indeed, 
substrate protein folding in the GroEL central cavity as described in the Anfinsen cage 
model has been repeatedly shown with several substrates including RuBisCo, mMDH, and 
rhodanese (Wang et al., 1998), as well as the use of the non-cycling single-ring mutant of 
GroEL for following GFP folding (Weissman et al., 1996), nicely addressed this cis cavity 
is central to allow folding to occur. 
One of the most convincing results that supported the cage model over the active 
unfolding model came from the work of Brinker et al (Brinker et al., 2001), where they 
applied a clever method to prevent released substrate proteins from rebinding to GroEL by 
coupling biotin to cysteine residues located at the apical domain of GroEL, together with the 
addition of streptavidin to rapidly and irreversibly block the entry to the cage. Under buffer 
conditions in which partly folded chains of RuBisCo readily aggregate, the addition of 
streptavidin after several ATPase reaction cycles blocked RuBisCo folding completely and 
instantly. This observation is inconsistent with the iterative annealing model, which predicts 
that some released chains would fold correctly in free solution. It is therefore in accord with 
the cage model, which predicts that correct folding occurs only within cage.        
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2.5. Aim of the study  
The basic mechanism of GroEL/GroES action involves encapsulation of a single 
molecule of non-native protein in a cage-like structure, thereby allowing folding to occur 
unimpaired by aggregation (Mayhew et al., 1996; Weissman et al., 1996). However, recent 
experimental findings together with theoretical analyses suggested that the physical 
environment of the chaperonin cage, in addition to providing a sequestrated folding space, 
may profoundly affect the energy landscape and the kinetic trajectories along which folding 
proceeds (Baumketner et al., 2003; Brinker et al., 2001; Jewett et al., 2004; Takagi et al., 
2003; Zhou, 2004). Evidence for such effect was provided for bacterial RuBisCo, a TIM 
barrel protein and model GroEL substrate. Folding of RuBisCo inside the cage occurred 
with a considerably faster rate than spontaneous folding, even when aggregation in free 
solution was avoided by adjusting protein concentrations to very low levels (Brinker et al., 
2001). This discovery offered the prospect of using the chaperonin system as an 
experimental tool to address a series of questions fundamental to our understanding of 
protein folding in general. 
 Although the theoretical analysis suggested that this rate enhancement is due to the 
spatial confinement of the folding protein, which would entropically destabilize unfolded 
conformations and reduce the search time for the energy basin of the compact native state 
(Baumketner et al., 2003; Takagi et al., 2003; Zhou, 2004), actual biochemical support  
illustrating this mechanism is still missing. To provide such information, here we performed 
a mutational analysis of the GroEL cavity to examine the structural features that play a 
critical role in accelerating folding. In probing the geometric confinement as a major 
contributor, we systematically reduced or increased the volume of the chaperonin cage and 
followed the consequences on folding speeds of different-sized model substrates. In 
addition, a number of conserved negative charges exposed on the cavity wall were also 
investigated for its impact in facilitating protein folding.   
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3. Materials and Methods 
3.1. Materials 
3.1.1. Chemicals  
 L-Amino acids Sigma-Aldrich 
Acetic acid Merck 
Adenosine 5′-(β,γ-imido)triphosphate tetralithium salt 
(AMP-PNP) 
Sigma-Aldrich 
Adenosine triphosphate, disodium salt (ATP) Sigma-Aldrich 
Agarose (SeaKem LE) Cambrex Bio Science  
Alexa Fluor 488 C5 maleimide  Molecular Probes 
Ammonium persulfate (APS) Sigma-Aldrich 
Ampicillin Merck  
Amylose resin New England Biolabs 
Arabinose Sigma-Aldrich 
Bacto agar Difco  
Bacto trypton Difco  
Bacto yeast extract Difco  
Bovine Serum Albumin (BSA) Sigma-Aldrich 
Bromophenol blue Sigma-Aldrich 
Calcium chloride Merck 
CDTA (trans-1,2-diaminocyylohexane-N,N,N’,N’-
tetracetic acid) 
Sigma-Aldrich 
Chloramphenicol Sigma-Aldrich  
Complete EDTA-free protease inhibitor Roche  
Coomassie brilliant blue R-250 Roth  
Dextran 40 Sigma-Aldrich 
Dimethylsulfoxide (DMSO) Merck 
DTSSP [3,3’-dithiobis(sulfo-succinimidylpropionate)] PIERCE 
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Dithiothreitol (DTT) Roche 
ECL™ detection kit Amersham Pharmacia Biotech  
Ethanol Merck 
Ethidium bromide BioRad  
Ethylenediaminetetraaceticacid –sodium salt (EDTA)  Merck 
Ferric nitrate Sigma-Aldrich 
Flavine adenine dinucleotide (FAD) Sigma-Aldrich 
Ficoll 70 Sigma-Aldrich 
Formaldehyde Sigma-Aldrich 
Glucose  Sigma-Aldrich 
Glycerol Merck 
Glycine Roth 
Guanidium hydrochloride (GuHCl) Sigma-Aldrich 
HEPES Sigma-Aldrich 
Hydrochloric acid (37%) Merck 
IANBD (N-((2-(iodoacetoxy) ethyl)-N-methyl) amino-
7-nitrobenz-2-oxa-1, 3-diazole ester 
Molecular Probes 
Imidazol  Merck 
Isopropyl-β-D-thiogalactopyranoside (IPTG) BioMol  
Kanamycin Sigma-Aldrich 
Magnesium chloride Merck 
Malachite green Sigma-Aldrich 
Maltose Sigma-Aldrich 
Menadione Sigma-Aldrich 
β-mercaptoethanol Sigma-Aldrich 
Methanol Merck 
Nickel-NTA agarose beads Qiagen 
Nicotinamide adenine dinucleotide (NADH) Roche 
PIPES Sigma-Aldrich 
Phenyl-methyl-sulfonyl-fluoride (PMSF) Sigma-Aldrich 
Polyacrylamide/bisacrylamide solution 30 % (30 : 0.8) Roth  
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Polyethylene glycol 2000 (PEG 2000) Merck 
Potassium  Cyanide Sigma-Aldrich 
Potassium hydroxide Sigma-Aldrich 
D-ribulose 1,5-diphosphate (RuDP) Sigma-Aldrich 
Silver nitrate Sigma-Aldrich 
Sodium chloride Merck 
Sodium [14C]bicarbonate Amersham Pharmacia Biotech 
Sodium dodecylsulfate (SDS) Sigma-Aldrich 
Sodium hydroxide Sigma-Aldrich 
Sodium thiosulfate Merck 
Spectinomycin Sigma-Aldrich 
Sucrose Merck 
N, N, N’, N’-Tetramethylethylendiamine (TEMED) Sigma-Aldrich  
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-
HCl) 
PIERCE 
Tris-base Sigma-Aldrich 
Triton X-100 Sigma-Aldrich  
Tween-20 Calbiochem 
 
3.1.2. Enzymes  
Apyrase Sigma-Aldrich 
Benzonase  Merck 
Lysozyme Sigma-Aldrich 
Pfu DNA polymerase Stratagene 
Restriction enzymes New England Biolabs  
Rhodanese Sigma-Aldrich 
Shrimp Alkaline Phosphatase Roche 
T4 DNA ligase New England Biolabs  
Vent DNA polymerase New England Biolabs 
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3.1.3. Materials 
Centricon 10 kDa cut-off Amicon 
Centricon 30 kDa cut-off Amicon 
High performance chemiluminescence film Amersham Pharmacia Biotech 
Microcon 10 kDa cut-off Amicon 
Microcon 30 kDa cut-off Amicon 
Nitrocellulose transfer membrane Whatman Schleicher & Schuell 
Sterile filter  0.22 μm Millipore 
Sterile filter  0.45 μm Millipore 
 
3.1.4. Instruments  
AIDA gel imaging software version 2.31 Raytest  
ÄKTA Explorer 100 Amersham Pharmacia Biotech 
Balance AG285, PB602 Mettler Toledo  
Centrifuges: Avanti J-25, Avanti J20 XP, J-6B, GS-6R Beckmann  
Centrifuges 5415C and 5417R Eppendorf  
Chromatography columns 
(HiPrep Desalting, MonoQ, HiTrap Heparin, 
Sephacryl S200/S300, Superdex 200, Superose 6,  
Sephadex G25 (NAP-5, NAP-10); chromatography 
resins: Q-Sepharose, DE52, Source 30 Q, Source 30 S) 
Amersham Pharmacia Biotech  
Deionization system MilliQ plus PF Millipore  
Electrophoresis chambers MiniProtean 3 Bio-Rad  
Electrophoresis power supply Power PAC 300 Bio-Rad 
Fluorescence spectrometer Fluorolog 3 HORIBA Jobin Yvon 
FPLC systems  Amersham Pharmacia Biotech  
EmulsiFlex high pressure homogenizer Avestin 
Gene Pulser II electroporation system Bio-Rad  
Gilson Pipetman (2, 10, 20, 100, 200, 1000 µl) Abimed  
Incubators Innova 4430 New Brunswick Scientific  
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Luminescent Image Analyzer LAS-3000 FUJIFILM 
Mini Trans-Blot Electrophoretic Transfer Cell Bio-Rad 
PCR-Thermocycler T3 Biometra  
pH meter Accumet Basic Fisher Scientific  
SMART system Amersham Pharmacia Biotech 
Sonicator Ultrasonic Processor XL Misonix Inc.  
Spectrophotometer DU 640 UV/VIS Beckmann  
Spectrophotometer LS50 Perkin-Elmer 
Synergy HT UV/VIS/fluorescence/luminescence  
plate reader 
Bio-Tek  
 
UV/VIS Spectrometer V-560 Jasco  
Thermomixer Comfort Eppendorf  
Vortex  Ikamag 
Water bath  Bioblock Scientific 
 
3.1.5. Media  
LB medium: 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl, (+ 15 g/l agar for 
solid medium). Adjusted to pH 7.0 with NaOH (Sambrook et al., 
1989). 
 
SOC medium 20 g/l tryptone, 5 g/l yeast extract, 0.5 g/l NaCl, 0.186 g/l KCl, 
0.95 g/l MgCl2. After autoclave, add 20 ml of filter sterilized 1M 
glucose (Sambrook et al., 1989). 
 
3.1.6. Antibiotic stock solutions 
Antibiotic additives to growth media were prepared as 1000x stock solutions and filter-
sterilized before usage: ampicilin: 100 g/l, kanamycin: 25 g/l, Chloramphenicol 25 g/l, 
Spectinomycin 50 g/l.  
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3.2. Bacterial strains and plasmids 
3.2.1. E. coli strains  
DH5α F’ 
 
F’/ endA1 hsdR17(rk-, mk+) glnV44 thi-1 recA1 gyrA 
(Nalr) relA1∆(lacIZYA-argF) U169 deoR 
(φ80dlac∆(lacZ)M15)  
 
BL21(DE3) Gold  
(Stratagene) 
B strain, F- dcm+ Hte ompT hsdS(rB- mB-) gal l 
(DE3) endA Tetr 
 
MC4100 
(Genevaux et al., 2004) 
F- araD139 ∆(argF-lac) U169 rpsL150 (Strr) relA1 
flbB5301 deoC1 pstF25 rbsR 
 
MC4100 SC3  
(Kerner et al., 2005) 
F- araD139 ∆(argF-lac) U169 rpsL150 (Strr) relA1 
flbB5301 deoC1 pstF25 rbsR PgroE::Para KanR 
 
3.2.2. Plasmids  
GroEL and all chaperonin mutants were constructed in a pCH vector backbone (Chang 
et al., 2005) inserted via the NdeI and NheI sites. Synthetic oligonucleotides encoding wild-
type or mutant C-terminal extensions of GroEL were introduced into the pCH-EL∆C or SR-
EL∆C plasmid between the NheI and HindIII sites. The SR-EL charge-mutants (SR-QNQ, 
SR-NNQ, SR-3N3Q, SR-KKK(1), SR-KKK(2), SR-D253N, SR-D253K, SR-D359N and 
SR-D359K) and MBP mutants (SM-MBP (Y283D), DM-MBP (V8G,Y283D), WT-MBP 
(D95C), SM-MBP (D95C), DM-MBP (D95C)) were generated by site-directed 
mutagenesis.  
GroES was constructed in a pET11a vector inserted via the NdeI and BamHI sites 
(Brinker et al., 2001).   
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Constructs for chaperonin in vivo co-expression experiments were prepared by cutting 
out GroEL-mutant DNA fragments between ClaI, BsaAI sites from pCH-EL plasmid series, 
and ligated into ClaI, Ecl136II cutted pOFXtacSL2 vector (Castanie et al., 1997). The 
resulting constructs are tac promoter driven, IPTG inducible with a p15A origin, which are 
compatible with ColEI constructs for co-expression.  
Constructs of WT and mutant MBP and MetF for in vivo experiments were generated by 
subcloning from the vectors described above into the arabinose promoter controlled vector 
pBAD18 (Guzman et al., 1995) via XbaI and HindIII sites.  
The sequences of all final constructs were confirmed by DNA sequencing (Sequiserve 
and Medigenomix GmbH). 
All DNA constructs used in this work are list in Table 2. 
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Table 2. The DNA consructs applied in this work  
Plasmid Promoter/ 
Origin 
Selection 
marker 
Purpose Reference 
(A) In Vitro 
GroEL and GroES     
pCH-EL T7/ColEI AmpR protein purification this work 
pCH-SR T7/ColEI AmpR protein purification this work 
pET11a-ES T7/ColEI AmpR protein purification this work 
     
GroEL size-mutant     
pCH-EL∆C T7/ColEI AmpR protein purification this work 
pCH-EL2[GGM]4 T7/ColEI AmpR protein purification this work 
pCH-EL3[GGM]4 T7/ColEI AmpR protein purification this work 
pCH-EL4[GGM]4 T7/ColEI AmpR protein purification this work 
pCH-EL[AAA]4 T7/ColEI AmpR protein purification this work 
pCH-EL[GGA]4 T7/ColEI AmpR protein purification this work 
pCH-EL2[GGA]4 T7/ColEI AmpR protein purification this work 
pCH-EL[GGA]4 [GGM]4 T7/ColEI AmpR protein purification this work 
pCH-SR T7/ColEI AmpR protein purification this work 
pCH-SR∆C T7/ColEI AmpR protein purification this work 
pCH-SR2[GGM]4 T7/ColEI AmpR protein purification this work 
pCH-SR3[GGM]4 T7/ColEI AmpR protein purification this work 
pCH-SR4[GGM]4 T7/ColEI AmpR protein purification this work 
pCH-SR[AAA]4 T7/ColEI AmpR protein purification this work 
pCH-SR[GGA]4 T7/ColEI AmpR protein purification this work 
     
GroEL charge-mutant     
pCH-SRD253N T7/ColEI AmpR protein purification this work 
pCH-SRQNQ T7/ColEI AmpR protein purification this work 
pCH-SRD359N T7/ColEI AmpR protein purification this work 
pCH-SRNNQ T7/ColEI AmpR protein purification this work 
pCH-SR3N3Q T7/ColEI AmpR protein purification this work 
pCH-SRD253K T7/ColEI AmpR protein purification this work 
pCH-SRKKK(1) T7/ColEI AmpR protein purification this work 
pCH-SRD359K T7/ColEI AmpR protein purification this work 
pCH-SRKKK(2) T7/ColEI AmpR protein purification this work 
     
GroEL substrates     
pCH-WTMBP T7/ColEI AmpR protein purification this work 
pCH-SMMBP T7/ColEI AmpR protein purification this work 
pCH-DMMBP T7/ColEI AmpR protein purification this work 
pCH-WTMBP D95C T7/ColEI AmpR protein purification this work 
pCH-SMMBP D95C T7/ColEI AmpR protein purification this work 
pCH-DMMBP D95C T7/ColEI AmpR protein purification this work 
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(B) In Vivo     
GroEL and EL mutants     
pOFXtacSL2 tac/ p15A CmR, SpcR Co-expression  (Castanie et al., 
1997) 
pOFXtacL2 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL∆C tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL2[GGM]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL3[GGM]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL4[GGM]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL[AAA]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL[GGA]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL2[GGA]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL[GGA]4 [GGM]4 tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSLNNQ tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSL3N3Q tac/ p15A CmR, SpcR Co-expression  this work 
pOFXtacSLKKK(2) tac/ p15A CmR, SpcR Co-expression  this work 
     
GroEL substrates     
pBAD18-WTMBP ara/ ColEI AmpR Co-expression this work 
pBAD18-SMMBP ara/ ColEI AmpR Co-expression this work 
pBAD18-DMMBP ara/ ColEI AmpR Co-expression this work 
pBAD18-MetF ara/ ColEI AmpR Co-expression this work 
 
 
3.3. Molecular cloning methods  
3.3.1. Preparation and transformation of E. coli competent cells  
For preparation of chemically-competent E. coli cells, a single colony was used to 
inoculate 500 ml LB medium (including antibiotic, if applicable) and grown to an optical 
density (OD600) of 0.25 - 0.5 at 37oC. The cells were then chilled on ice for 15 min and 
harvested at 5000 x g for 10 min at 4°C. The cell pellet was washed with 80 ml ice-cold 
Ca/glycerol buffer (10 mM PIPES, 60 mM CaCl2, 15 % glycerol; pH 7.0, adjusted with 
NaOH, and filter-sterilized) once and incubated with additional 80 ml Ca/glycerol buffer on 
ice for 30 min. Finally, the cells were pelleted and resuspended in 6 ml of Ca/glycerol buffer. 
100 μl aliquots were frozen in liquid nitrogen and stored at –80oC. 
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For transformation, ~50 µl competent cells were mixed with 0.05 - 0.2 µg plasmid DNA 
or 1-5 µl ligation reaction and incubated on ice for 15 min. The cells were heat-shocked at 
42oC for 45-90 s and subsequently placed on ice for 2 min. 1 ml of LB medium was added 
and the cells were shaken at 37oC for 1 h. The cell suspension was then plated on selective 
plates and incubated at 37oC, until colonies had developed (typically 10-16 h). 
Alternatively, electroporation was applied to improve the transformation efficiency.  
Electrocompetent cells were prepared as follows: 500 ml bacterial culture was grown to an 
optical density (OD600) of 0.8 in LB medium at 37oC.  The cells were washed carefully with 
250 ml ice-cold sterilized water for two times and finally the cells were pelleted and 
resuspended in 2 ml of ice-cold 10% glycerol. 40 μl aliquots were frozen in liquid nitrogen 
and stored at –80oC. For electroporation transformation, competent cells (40 µl) were mixed 
with 1-2 µl plasmid DNA (or ligation product) and transferred into a 0.2 cm Gene Pulser 
cuvette. The electroporation was done at 2.5 kV, 25 μFD and 200Ω settings with a Gene 
Puser II elecporation device. The transformed cells were allowed to recover in 1 ml of SOC 
medium with 225 rpm shaking at 37oC for 1 h. The cell suspension was then plated on 
selective plates and incubated until colonies had developed (Dower et al., 1988). 
 
3.3.2. Plasmid purification 
LB medium containing the appropriate antibiotic was inoculated with a single E. coli 
colony harboring the DNA plasmid of interest and shaken 8 – 16 h at 37oC. Plasmids were 
isolated using the QIAprep Spin Miniprep Kit or QIAGEN Plasmid Midi Kit (Qiagen) 
according to the manufacturer’s instructions. 
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3.3.3. PCR amplification  
PCR (polymerase chain reaction)-mediated amplification of DNA was performed 
according to a standard protocol with minor modifications: 
DNA Template: 10-20 ng (plasmid DNA) 
250 ng or less (bacterial genomic DNA) 
Primers: 20 pmol each 
dNTPs: 200 µM each 
Pfu DNA Polymerase: 2.5 U 
Polymerase buffer: 1 x 
Additives: 3-6 % DMSO if GC content was >50 %, 
Final volume: 50 µl 
 
Cycling conditions (35 cycles): 
Initial denaturation: 94°C, 5 min 
Cycle denaturation: 94°C, 30-60 s 
Annealing: ~55°C, 30-60 s 
Extension: 72°C, duration dependent on template length:  
1 kbp/min. 
Final Extension: 72°C, 10 min. 
Stored at 4°C or -20°C.  
 
PCR products were further purified using the QIAquick PCR purification and gel 
extraction kits (Qiagen) according to the manufacturer’s instructions. 
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3.3.4. DNA restriction and ligation 
DNA restriction was performed according to the manufacturer’s instructions (New 
England Biolabs) of the respective enzymes. Typically, a 50 µl reaction contained 1-2 µl of 
each restriction enzyme and 0.5-2 µg purified PCR product or 1-5 µg plasmid DNA in the 
appropriate reaction buffer. Digested vector DNA was dephosphorylated with shrimp 
alkaline phosphatase. 
For ligation, 100-200 ng (~1-2 µl) dephosphorylated vector DNA, 100-200 ng (~5-10 µl) 
DNA insert and 1 µl (100 U) T4 ligase were incubated in ligase buffer at 25°C for 1 h or, for 
increased efficiency, at 16°C overnight.  The ligation product was transformed into 
competent E. coli DH5α cells as described. 
 
3.3.5. DNA analytical methods 
DNA concentrations were measured by UV absorption spectroscopy at λ = 260 nm. A 
solution of 50 µg/ml of double stranded DNA in H2O exhibits approximately A260 nm = 1. 
Agarose gel electrophoresis was performed in TAE buffer (40 mM Tris, 1 mM EDTA, 
20 mM acetic acid) and 1 – 2 % TAE-agarose gels, supplemented with 1 µg/ml ethidium 
bromide, at 4 – 6 V/cm. 
DNA sequencing was performed by Medigenomix GmbH (Martinsried, Germany) or 
Sequiserve (Vaterstetten, Germany). 
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3.4. Protein purification 
Proteins DnaK, DnaJ, GrpE (Hayer-Hartl et al., 1996) and RuBisCo from R. rubrum  
were obtained from the Hartl laboratory collection of purified proteins.  
 
3.4.1. GroEL expression and purification  
GroEL was purified with modifications to the protocol described by Hayer-Hartl et al.  
(1996). E. coli BL21 (DE3) Gold cells harboring the plasmid pCH-GroEL were grown in 6 l 
LB medium containing 100 mg/l ampicillin at 37°C to OD600 of ~0.5. The induction was 
then proceeded by the addition of 1 mM (final concentration) of IPTG to the culture for 5-6 
h. After harvesting the cultures by centrifugation for 30 min at 2500 x g, cells were 
resuspended in 100 ml lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT, 1 
mM EDTA) and Complete protease inhibitor (1 tablet/25 ml). The suspension was further 
treated with lysozyme (~0.5 mg/ml) and benzonase (~500 units) for 60 min at 4oC. Lysis 
was achieved by homogenization of the cell suspension in an EmulsiFlex C5 device kept on 
ice. Cell debris was removed by ultracentrifugation for 60 min at 40,000 x g, 4°C and the 
supernatant subsequently passed through 0.2 µm filter. The supernatant was applied to a 400 
ml DE52 column attached to an ÄKTA Explorer chromatography system. After washing 
with two column volumes of the lysis buffer, the protein was eluted using a NaCl gradient 
from 50 mM to 600 mM in five column volumes. The GroEL containing fractions were 
collected and dialyzed in 5 l lysis buffer overnight at 4oC. The deslated supernatant pool was 
applied onto a 20 ml MonoQ column, equilibrated in 30 mM Tris-HCl pH 7.5, 1 mM DTT, 
1 mM EDTA and GroEL eluted with a NaCl gradient from 0 to 0.5 M. GroEL containing 
fractions were collected and dialyzed against 30 mM Tris-HCl pH 7.5, 30 mM NaCl, 1 mM 
DTT and 1 mM EDTA. The sample was then applied to a 4 x 5 ml Heparin Sepharose 
column (HiTrap Heparin) and eluted with 30 mM Tris-HCl pH 7.5 with a NaCl gradient 
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from 0 to 0.5 M NaCl. GroEL-eluted flowthrough was collected and concentrated to less 
than 5 ml in 50 kDa cut-off Centriprep concentrators. Finally the concentrated sample was 
applied to a Sephacryl S 300 (XK 26/60) size exclusion column equilibrated in 30 mM Tris-
HCl pH 7.5, 30 mM NaCl, 1 mM DTT, 1 mM EDTA and 10 % glycerol. GroEL oligomer 
(approximate size 800 kDa) fractions were collected and concentrated to ~ 35 mg/ml 
(equivalent to 44 μM of GroEL oligomer). Protein concentration was determined based on 
extinction coefficient of GroEL (ε280=126,800 M-1cm-1). And aliquots were flash frozen in 
liquid N2 and stored at -80°C. Total yield of GroEL was typically ~ 600 mg.   
 
3.4.2. GroES expression and purification  
The expression and purification of GroES was similar as GroEL as described above, 
including the induction, lysis and centrifugation procedures. The supernatant was applied to 
a 400 ml DE52 column attached to an ÄKTA Explorer chromatography system. After 
washing with two column volumes of the above buffer, the protein was eluted using a NaCl 
gradient from 50 mM to 500 mM in five column volumes. GroES containing fractions were 
collected and dialyzed in 5 l lysis buffer overnight at 4oC. The deslated pool was applied 
into a 20 ml MonoQ column. Proteins were eluted in 30 mM Tris-HCl pH 7.5, 1 mM DTT, 
1 mM EDTA and a NaCl gradient from 0 to 0.5 M. GroES containing fractions were 
collected and concentrated to less than 5 ml in 10 kDa cut-off Centriprep concentrators. The 
concentrated sample was finally applied to a Sephacryl S 200 (XK 26/60) size exclusion 
column equilibrated in 30 mM Tris-HCl pH 7.5, 30 mM NaCl, 1 mM DTT, 1 mM EDTA 
and 10 % glycerol. GroES oligomer (approximate size 70 kDa) fractions were collected and 
concentrated to ~ 15 mg/ml based on extinction coefficient of GroES (ε280=8,943 M-1cm-1). 
Aliquots were frozen in liquid N2 and stored at -80°C. Total yield of GroES was typically ~ 
400 mg.  
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3.4.3. MBP and MBP mutants expression and purification  
MBP and MBP mutants were purified using an amylose affinity column (New England 
Biolab). E. coli BL21 (DE3) Gold cells harboring the plasmid pCH-MBP wild-type and 
pCH-MBP mutants were grown in 6 l LB medium containing 100 mg/l ampicillin at 37°C to 
OD600 of ~0.1. The induction was then proceeded by adding 0.1 mM final concentration of 
IPTG to the culture for 12-16 h at 25oC. After harvesting the cultures by centrifugation for 
30 min at 2500 x g, cells were resuspended in 100 ml amylose buffer (20 mM Tris-HCl pH 
7.5, 200 mM NaCl, 1 mM DTT, and 1 mM EDTA) containing Complete protease inhibitor 
(1 tablet/25 ml). The same lysis and centrifugation conditions as used for GroEL 
purification were applied here. The supernatant was next dialyzed in amylose buffer to 
remove cellular maltose and slowly loaded on to a 100 ml amylose column. After washing 
with 12 column volumes of amylose buffer, MBP was eluted with amylose buffer 
containing 10 mM maltose. Fractions containing MBP were collected and dialyzed in 5 l 
amylose low salt buffer (20 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT, and 1mM 
EDTA) overnight at 4oC.  MBP was concentrated to 10 mg/ml, and aliquots were frozen in 
liquid N2 and stored at -80oC. Typical yield of WT-MBP from 6 l culture was ~ 500 mg, 
while the SM-MBP, DM-MBP gave yields of ~200 mg and ~100 mg respectively, due to 
largely partition of the expressed protein in the insoluble fractions. Protein concentration 
was determined using extinction coefficient of ε280=64,720 M-1cm-1 of WT-MBP, 
ε280=63,440 M-1cm-1 of SM-MBP and DM-MBP.  
 
3.4.4.  MetF expression and purification  
MetF was expressed at 30oC in E. coli cells harboring elevated level of GroEL and 
GroES (Kerner et al., 2005). Cells were harvested and resuspended in running buffer (50 
mM Tris-HCl pH 7.3, 300 mM NaCl) containing Complete EDTA-free protease inhibitor (1 
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tablet/ 25 ml). Lysis was achieved by homogenization of the cell suspension in an 
EmulsiFlex high pressure homogenizer device and the lysate was cleared by centrifugation 
at 40,000 x g for 1 h, 4oC. The supernatant was applied to a 5 ml HiTrap metal chelating 
column pre-charged with Ni2+. The column was washed with a gradient of 10 to 50 mM 
imidazole in running buffer (for over 10 column volumes) and the proteins were eluted with 
250 mM imidazole in running buffer. Fractions containing MetF were dialyzed in 20 mM 
MOPS-KOH, pH 7.4, 200 mM NaCl. MetF concentration was determined based on the 
absorption of bound FAD at 447 nm (ε280=14,300 M-1cm-1) (Sheppard et al., 1999). 
Proteins were aliquoted, flash-frozen in liquid N2 and stored at -80 ºC. 
  
3.4.5. Rhodanese preparation  
Bovine mitochondrial rhodanese was purchased from Sigma (R-1756). 11.5 mg 
rhodanese was dissolved in 600 μl rhodanese buffer (20 mM MOPS-NaOH, pH 7.4, 50 mM 
NaCl). Impurities were removed by ultracentrifugation for 20 min at 4oC and ~20,000 x g. 
The supernatant was transferred to a new vial and the protein concentration was determined 
using extinction coefficient (ε280=59,840 M-1cm-1). Proteins were aliquoted and stored at -
80ºC. 
 
3.5. Protein analytical methods 
3.5.1. Determination of protein concentration  
Protein concentrations were determined spectrophotometrically by A280 (in 6 M GuHCl), 
based on the theoretical extinction coefficient of the respective protein at λ=280 nm (Gill 
and von Hippel, 1989) as calculated by the ProtParam tool at the ExPASy proteomics server 
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(http://www.expasy.org). Molar concentrations of chaperones are expressed for the native 
state oligomer, while the GroEL substrates are presented as monomer. 
 
3.5.2. SDS-PAGE   
SDS-Polyacrylamide gels were prepared as follows: 
4 % stacking gels and 10 %, 12 % or 15 % sepqrating gels were prepared according the 
following recipe:  
Chemicals Stacking gel Separating gel 
 4 % 10 % 12 % 15 %
30 % Acryalmide (0.8% bis) 6.5 ml 16.7 ml 20 ml 25 ml
0.5 M Tris, pH 6.8 12.5 ml      _       _      _ 
1.5 M Tris, pH 8.8         _ 12.5 ml 12.5 ml 12.5 ml
10 % SDS 0.5 ml 0.5 ml 0.5 ml 0.5 ml
2M Sucrose        _ 12.5 ml 12.5 ml 12 ml
H2O (up to 50 ml) 30.5 ml 7.8 ml 4.5 ml      _ 
TEMED 50 μl 25 μl 25 μl 25 μl
10% APS 500 μl 500 μl 500 μl 500 μl
SDS-PAGE was performed using a discontinuous buffer system (Laemmli, 1970) in 
BioRad Mini-Protean 3 electrophoresis chambers employing a constant current of 30 
mA/gel in 50 mM Tris-Base, 380 mM glycine, 0.1 % SDS (pH 8.3). Protein samples were 
prepared for SDS-PAGE by mixing with 5x Laemmli buffer (Laemmli, 1970) (final 
concentration of 1x Laemmli buffer: 60 mM Tris-HCl, pH6.8, 1% SDS, 10 % glycerol, 
0,01% Bromophenol blue, 0,1 mM β-mercaptoethanol) and boiling samples at 95oC for 3-5 
min before loading onto a gel. After electrophoresis, gels were stained with Coomassie blue 
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staining solution (0.1 % Coomassie brilliant blue R-250, 40 % ethanol, 7 % acetic acid) for 
1 h or longer and destained in 20 % ethanol, 7 % acetic acid. 
 
3.5.3. Western-blotting 
Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes in a 
Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad) in 25 mM Tris, 192 mM glycine, 
20 % methanol, pH 8.4 at constant current of 150 mA/gel for 1 h (Towbin et al., 1979). 
Nitrocellulose membranes were blocked in 5 % skim milk powder in TBST (50 mM Tris-
HCl, pH8.0, 150 mM NaCl, 0.05% Tween 20) for 1 h. The membranes were then incubated 
with a 1:2000 – 1:10,000 dilution of primary antibody serum in TBST for 2 h and 
extensively washed in TBST before incubation with a 1:5000 (for anti-mouse IgG) or 
1:10,000 (for anti-rabbit IgG) dilution of secondary antibody in TBST (anti-rabbit IgG and 
anti-mouse IgG, whole molecule – horseradish peroxidase conjugate, Sigma-Aldrich). After 
extensive washing, protein bands were detected by incubating the membranes with ECL 
chemiluminescence solution and exposure to X-ray film (High performance 
chemiluminescence film) or a Luminescent Image Analyzer LAS-3000 system. 
 
3.5.4. Sliver staining 
Polyacryamide gels were fixed in fix solution (50 % methanol, 5% acetic acid) for at 
least 1 h and briefly soaked into incubation solution (0.02% sodium thiosulfate) for 1 min. 
After rinsing in water twice, gels were incubated in silver solution (0.2 % silver nitrate with 
0.06% v/v formaldehyde) for 20 min and staining initiated by the developing solution (6% 
sodium carbonate, 0.0002% sodium thiosulfate with 0.04% v/v formaldehyde) until the 
desired signal intensity appeared. Further color development was stopped by incubation in 
10% acetic acid for 10 min.  
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3.6. GroEL functional activity assays 
3.6.1. ATPase assay 
GroEL (0.2 µM oligomer) was incubated in buffer (20 mM Tris-HCl, pH 7.5, 200 mM 
KCl, 5 mM MgCl2) for 5 min at 37oC, and GroES was present at a 2-fold molar excess over 
GroEL. The reaction was initiated at 37oC by the addition of 2 mM ATP. The kinetics of the 
ATPase activities of GroEL and GroEL/GroES were followed for 0- 20 min with time points 
taken every 2.5 min. ATPase activity at the various time points was stopped by the addition 
of 15 mM CDTA. Quantification of liberated inorganic phosphate was performed by the 
malachite green assay (Lanzetta et al., 1979). After 30 min incubation at 25oC, the 
absorption was followed at 637 nm. A calibration curve of inorganic phosphate (0–20 nmol) 
was measured as linear range control in parallel. Spontaneous ATP hydrolysis was not 
observed under the conditions used. 
 
3.6.2. Aggregation prevention assay of denatured rhodanese  
Rhodanese (25 μM) was denatured for 1 h at 25oC in denaturing buffer (6 M GuHCl, 20 
mM Tris-HCl, pH 7.5, 20 mM KCl, 5 mM MgCl2 , 5 mM DTT) and diluted 100-fold into 
buffer A (20 mM Tris-HCl, pH 7.5, 200 mM KCl, 5 mM Mg(OAc)2) alone or  into buffer A 
containing 0.25 μM GroEL (oligomers). Aggregation was monitored by light scattering at 
320 nm (Weber et al., 1998). Values indicating aggregation in buffer A after 10 min is set to 
100%.   
 
3.6.3. Surface plasmon resonance (SPR)  
SPR measurements were performed on a BIAcore 2000 instrument (Brinker et al., 2001; 
Hayer-Hartl et al., 1995). All buffers used for SPR were filtered (0.2 μm) and degassed. All 
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SPR analyses in this work were in buffer A at a flow rate of 20 μl/min at 25oC. To 
immobilized GroES-His6 on a chelating NTA biosensor chip, NTA was first loaded with 
Ni2+ by injection of 20 μl 0.5 mM NiCl2, GroES was then immobilized on flow cell 1 and 3 
(resulting in 50-100 RU), leaving flow cell 2 and 4 as buffer reference. 250 nM GroEL 
oligomer was injected in buffer (20 mM Tris-HCl, pH 7.5, 200 mM KCl, 5 mM Mg(OAc)2) 
plus the indicated nucleotides, followed by its dissociation kinetics for 10 min.  
 
3.7. In vitro protein refolding and activity assays  
Protein refolding reactions containing chaperones (when present) were carried out with 
the following molar concentration ratios of chaperones to substrate: 
1 substrate (monomer) : 2 GroEL (tetradecamer) : 4 GroES (heptamer) . 
 
3.7.1. MBP Refolding 
WT-MBP and mutants (25 μM) were denatured in 6 M GuHCl, 20 mM Tris-HCl, pH 
7.5, 20 mM KCl for 1 h at 25oC and refolded upon 100-fold dilution into high salt buffer A 
(20 mM Tris-HCl, pH 7.5, 200 mM KCl, 5 mM Mg(OAc)2) or low salt buffer B (20 mM 
Tris-HCl, pH 7.5, 20 mM KCl, 5 mM Mg(OAc)2) in the absence or presence of chaperones. 
GroEL/GroES assisted refolding was initiated at 25oC by the addition of 5 mM ATP. 
Intrinsic tryptophan fluorescence was monitored on a Fluorolog 3 Spectrofluorometer 
(Spex) with an excitation wavelength of 295 nm (slit width 2 nm) and an emission 
wavelength of 345 nm (slit width 5 nm)(Chun et al., 1993).  
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3.7.2. MetF Refolding 
MetF (50 μM) was denatured with 6 M GuHCl in buffer A containing 10 mM DTT for 
1 h at 25oC and refolded upon 100-fold dilution into buffer A containing 50 µM FAD and 1 
g/L BSA at 25oC in the absence or presence of chaperones. A 2-fold molar excess of GroES 
over GroEL was added and refolding initiated with 5 mM ATP. At the times indicated, 
aliquots were taken and reactions stopped with 40 mM CDTA. MetF activity was measured 
at 25oC using an NADH-menadione oxidoreductase assay as described previously 
(Sheppard et al., 1999).    
 
3.7.3. Rhodanese Refolding 
Rhodanese (50 μM) was denatured for 1 h at 25oC in denaturing buffer (6 M GuHCl, 20 
mM Tris-HCl, pH 7.5, 20 mM KCl, 5 mM MgCl2 , 5 mM DTT) and refolded upon 100-fold 
dilution into buffer A or B supplemented with chaperones as indicated in the figure legends. 
A 2-fold molar excess of GroES over GroEL was added and refolding initiated with 5 mM 
ATP. At the times indicated, further refolding were stopped with 50 mM CDTA and 
rhodanese activity measured at 460 nm at 25oC, as previously described (Hayer-Hartl et al., 
1996; Martin et al., 1991). 
 
3.7.4. RuBisCo Refolding 
RuBisCo (50 μM) was denatured in 6 M GuHCl, 50 mM Tris, pH 7.8, 1 mM EDTA, 10 
mM DTT  for 1 h at 25oC and diluted 100-fold into buffer A or B containing 1 mg/ml BSA, 
5 mM DTT, supplemented with chaperones as indicated in the figure legends. Assisted 
refolding was initiated by adding 2-fold molar excess of GroES over GroEL and 5 mM 
ATP. At the times indicated, aliquots were withdrawn and rapidly mixed with solution 
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containing 7.5 mM CDTA and apyrase to stop GroEL action and RuBisCo refolding. 
Enzymatic activity was determined after incubation at 25oC for 1 h as described in Brinker 
et al (2001). 
 
3.8. Biochemical and biophysical methods   
3.8.1. Thermal denaturation of MBP 
Temperature denaturation of MBP was monitored by circular dichroism spectroscopy 
(Jasco J-715) at 222 nm in buffer A. Thermal denaturation was carried out from 20- 90oC 
with a heating rate of 0.5oC per min and monitored at 222 nm. After incubation at 90oC for 
30 min the sample was cooled to 20oC. The midpoint of thermal denaturation (Tm) for 2.5 
μM MBP wild-type and mutants were determined by fitting the circular dichroism signal to 
a two state transition model. 
 
3.8.2. Equilibrium unfolding of MBP  
The equilibrium unfolding of MBP (0.25 µM) was performed at 25oC in buffer A 
containing 0−1.5 M GuHCl and followed by intrinsic tryptophan fluorescence at 345 nm. 
Equilibrium unfolding curves fit a two state transition.  
 
3.8.3. Fluorescence assay of maltose binding to MBP 
MBP D95C mutants (50 μM) (Marvin et al., 1997) were labeled in buffer C (100 mM 
HEPES, pH 7.8, 1 mM TCEP, 2 mM EDTA) for 4 h on ice in the presence of a 20-fold 
excess of the fluorophore IANBD (N-((2-(iodoacetoxy) ethyl)-N-methyl) amino-7-
nitrobenz-2-oxa-1, 3-diazole ester, Molecular Probes, Inc.). Unbound fluorophore was 
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removed using micro Bio-Gel P6 columns (BIO-RAD) equilibrated in buffer B. The 
coupling efficiency measured by the absorption of MBP (ε280 = 69,000 M-1cm-1) and IANBD 
(ε472 = 23,000 M-1cm-1) was > 90%. IANBD fluorescence was monitored at 538 nm (slit 
width 8 nm) with an excitation wavelength at 470 nm (slit width 2 nm) at 25oC. During a 
typical MBP refolding experiment as described in section 3.7.1.,  5 mM maltose were either 
present through the fluorescence measurement, or added at the end of refolding to confirm 
the native status of refolded MBP. 
 
3.8.4. Fluorescence anisotropy  
MBP D95C mutants (50 μM)  were labeled in buffer C for 12 h on ice with a 2.5-fold 
excess of Alexa Fluor 488 C5 maleimide (Molecular Probes). Unbound fluorophore was 
removed as above. The coupling efficiency measured by the absorption of MBP (ε280 = 
69,000 M-1cm-1) and Alexa 488 C5 maleimide (ε493 = 72,000 M-1cm-1) was > 90%. Steady 
state fluorescence anisotropy was monitored at the emission wavelength of 518 nm (slit 
width 7 nm) with an excitation wavelength at 495 nm (slit width 5 nm) at 25oC using a LS50 
spectroflurometer (Perkin-Elmer). 
 
3.8.5. Proteinase K protection of GroEL-GroES substrate complex 
Rhodanese, DM-MBP or RuBisCo (25 μM each) was denatured in GuHCl as described 
and diluted 100-fold into buffer A or B in the presence of a 2- or 4-fold molar excess of 
GroEL or SR-EL, respectively, at 25oC. Treatment with proteinase K (2 μg/ml) was 
followed for 0-20 min . At the indicated times, sample was removed and further proteolysis 
was stopped with 1.5 mM PMSF. Protease protection of substrate protein by GroEL-GroES 
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complex was determined by immunoblotting and quantification by Aida Image Analyzer v. 
3.52.  
 
3.8.6. Intermolecular crosslinking of MBP 
Crosslinking with DTSSP [3,3’-dithiobis(sulfo-succinimidylpropionate)] was performed 
according to the manufacturer’s instruction (PIERCE). Native or GuHCl denatured MBP 
(25, 50, 100, 200 μM) was diluted 100-fold into 20 mM MOPS pH 7.5, 200 mM KCl and 5 
mM MgCl2  containing 0.5 mM DTSSP. After incubation at 25oC for 60 min crosslinking 
was quenched by addition of 1M Tris, pH 7.4 to a final concentration of 50 mM with further 
incubation for 15 min. Samples were analyzed by SDS-PAGE under non-reducing 
conditions followed by sensitive silver staining. A small amount of crosslinked MBP was 
only observed with the denatured protein during refolding at a final MBP concentration 
greater than 1 µM. 
 
3.9. In vivo assays 
3.9.1. Solubility of MBP and MetF in vivo 
E. coli MC4100 strain containing the plasmid pOFXtac-SL2 , expressing GroEL/GroES 
or EL-mutants/GroES, was transformed with the arabinose-controlled expression plasmid 
(pBAD 18) for MBP or MetF. Cells were grown in LB medium at 37oC to an OD600=0.8, 
and chaperonins were induced with 0.1 mM IPTG for 1 hour before induction of substrate 
protein with 0.2% arabinose for 1 hour. Cells were harvested by centrifugation (5000 x g, 5 
min) and spheroplasts were prepared as following (Ausubel et al., 2003): 3 OD600 units cell 
pellet was resuspended in 100 μl of 50 mM Tris-Cl, pH 8.0, 20% sucrose, followed by 
additing 20 μl of 5 mg/ml lysozyme solution and incubating the cells on ice for 5 min. 40 ul 
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of 20 mM of EDTA were further added and the cells were incubated on ice for 5 min. 
Finally, the cell suspension was mixed with 40 μl of 50 mM Tris-Cl, pH 8.0 and the 
incubation temperature was shifted to 37oC for 5 min. Spheroplasts were lysed by dilution 
into an equal volume (200 μl) of 2x lysis buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 
10 mM MgSO4, 0.2% Triton X-100, Complete EDTA-free protease inhibitors, 100 U/ml 
Benzonase). Aliquots were fractionated into supernatant and pellet by centrifugation at 
20,000 x g for 30 min and analyzed by 12% SDS-PAGE and Coomassie blue staining or 
immunoblotting, as indicated. 
 
3.9.2. Complementation assay of GroEL/GroES depletion strain 
A GroEL depletion strain, MC4100 SC3 where the chromosomal groE promoter is 
replaced with the araC gene and the pBAD promoter, and a kanamycin resistance (KanR) 
cassette is immediately upstream of groE (transcribed in the reverse orientation) was a 
generous gift from C. Gerogopoulos (University of Geneva, Switzerland).  
E. coli MC4100 SC3 cells harboring plasmids pOFXtac-SL2 series, expressing 
GroEL/GroES or EL-mutants/GroES were grown in LB- 0.05 % arabinose medium at 37oC 
to OD600 = 1 (~7 h), where cell numbers were predetermined to be similar among all strains 
tested (~5 x 108 cells/ml) based on colony counting results. After confirming the OD600 
values of the cultures, serial dilutions were made to give 5 x 104, 5 x 103, 5 x 102, 5 x 101 
cells/ 5 μl suspension, and spotted them on either LB-Spe50 plate containing 0.05 % 
arabinose or 1 mM IPTG. Plates were scanned after 16 h incubation.  
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4. Results 
4.1. GroEL/GroES can accelerate MBP folding more than 
ten-fold 
4.1.1. MBP as a suitable model substrate to study the rate of chaperonin 
assisted folding  
To explore how encapsulation actively accelerates the folding reaction, a suitable 
substrate is required for further study. Since the obligate GroEL dependent substrate 
proteins were shown to aggregate upon in vitro refolding (Kerner et al., 2005), it is difficult 
to compare their spontaneous and chaperonin-assisted folding rates.  To avoid this 
complication, we explored the suitability of MBP as a model substrate, based on previous 
reports that GroEL/GroES can increase the folding speed of a mutant form of MBP 
(Beissinger et al., 1999; Sparrer et al., 1997). 
MBP is a periplasmic E. coli protein that is involved in sugar transport as a primary 
acceptor for maltose and maltodextrin (Spurlino et al., 1991). It is synthesized in the cytosol 
as a precursor containing a 26-residue signal peptide at the N-terminus; however it folds 
robustly in the cytosol when expressed without its cleavable N-terminal export sequence. 
MBP is composed of two globular domains formed by discontinuous sequence elements 
consisting of secondary structural βαβ units, with the binding site for maltose located in a 
cleft between the domains (Figure 12) (Spurlino et al., 1991).  
MBP has several properties that make it desirable as a folding substrate: firstly, MBP is 
a monomeric protein (~41 kDa) which does not require an assembly step upon release from 
the chaperone.  Secondly, in vitro refolding of MBP has been extensively characterized 
(Chun et al., 1993) and it folds spontaneously up to a concentration of 1 to 2 μM (Ganesh et 
al., 2001). Thirdly, MBP possesses eight tryptophans (10, 62, 94, 129, 158, 230, 232 and 
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340) distributed over both domains (Figure 12); thereby the formation of its native state 
results in a dramatic enhancement in intrinsic tryptophan fluorescence, the tryptophan 
fluorescence signal is reduced 5-fold upon unfolding, and the recovery of fluorescence can 
be used as a measure of folding (Chun et al., 1993).. Importantly, it is possible to 
continuously monitor the formation of native MBP protein both in the presence and absence 
of GroEL/GroES, which lack tryptophans in resulting significant fluorescence background.  
 
 
Figure 12.  Ribbon diagram of the tertiary structure of MBP.  
The two discontinuous domains are shown in blue and orange (N-domain: 1-109 and 264-
309, C-domain: 114-258 and 316-370), respectively, the eight tryptophans in red. Positions 
of mutated amino acids (V8G and Y283) are indicated in green. The structure was adapted 
from Spurlino et al., (1991) (PDB code: 1OMP) and figure was generated with SwissPDB-
Viewer v3.7 and POV-Ray v3.6.  
 
The spontaneous rate of folding of wild-type MBP (WT-MBP) is very fast; therefore 
WT-MBP is not a suitable substrate for following folding rate enhanced by GroEL. 
However, several slow folding mutants of MBP are known and we analyzed two of these, 
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the single mutant Y283D (SM-MBP) and the double mutant V8G/Y283D (DM-MBP) 
(Chun et al., 1993; Wang et al., 1998). Both mutations, V8G and Y283D, are located in the 
N-domain, in close proximity in a strand and loop segment, respectively (Figure 12). 
Formation of native contacts within the N-domain is rate-limiting for MBP folding and is 
therefore slowed by these mutations (Chun et al., 1993). 
As monitored by tryptophan fluorescence, at 25oC, WT-MBP rapidly refolded with an 
apparent rate of ~0.03 s-1 (t1/2 ~25 s), upon dilution from 6 M guanidine-HCl (GuHCl) into 
the refolding buffer. In addition, SM-MBP and DM-MBP refolded to full yield but with ~7-
fold (t1/2 ~175 s) and ~75-fold (t1/2 ~1900 s) slower rates, respectively (Figure 13 and 
Supplemental Table S1). 
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Figure 13. Spontaneous refolding of wild-type and mutant MBP  
Refolding of GuHCl-denatured MBP (25 μM) at 25oC upon 100-fold dilution into buffer A. 
Wild-type MBP was indicated in black, SM-MBP in green and DM-MBP in red. The 
maximum recovery of tryptophan fluorescence was set to 1 (~100% of native MBP control). 
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Importantly, the slower folding rates of MBP mutants are not due to lower stabilities of 
their final states. We applied temperature and denaturant-dependent unfolding experiments 
and demonstrated that the native states of SM-MBP and DM-MBP were only moderately 
destabilized relative to WT-MBP (Figure 14 and Supplemental Table S1A). This indicates 
that these three proteins are equivalently stable in the further experimental conditions.  
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 Figure 14. Folding properties of WT-MBP and MBP mutants 
(A) Thermal denaturation of MBP monitored by circular dichroism (Jasco J-715) at 222 nm 
in buffer A. WT-MBP is indicated in black, SM-MBP in green and DM-MBP in red. (B) 
The equilibrium unfolding of WT-MBP and MBP mutants (0.25 μM) at 25oC in buffer A 
containing 0-1.5 M GuHCl, followed by intrinsic tryptophan fluorescence at 345 nm. Both 
the thermal denaturation and equilibrium unfolding curves fit a two state transition. Thermal 
denaturation was fully reversible. 
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4.1.2. Folding acceleration of MBP is GroEL dependent in a noncycling 
manner   
To test whether GroEL can bind denatured MBP, we first incubated the denatured 
substrates in absence or presence of nucleotide together with only GroEL, we found that in 
the absence of ATP, GroEL inhibited the spontaneous folding of WT-MBP and two mutant 
proteins, indicating GroEL can efficiently recognize all three unfolded MBP. Proteins in the 
presence of ATP, slow refolding was only observed with SM-MBP and DM-MBP, whereas 
WT-MBP refolded with kinetics similar to spontaneous folding, suggesting that the SM-
MBP and DM-MBP bury hydrophobic residues more slowly, and allowing efficient GroEL 
rebinding. Strikingly, substantial acceleration of SM-MBP and DM-MBP folding was 
observed upon addition of the complete GroEL/GroES system and ATP, in which the 
folding rate of SM-MBP was accelerated ~3-fold compared to spontaneous folding and that 
of DM-MBP was accelerated ~13-fold (Figure 15A-C and Supplemental Table S1). 
Spontaneous folding of WT-MBP was rapid and efficient and no further enhancement by 
the GroEL/GroES system was observed.  
In contrast to GroEL/GroES, the bacterial Hsp70 chaperone system, consisting of 
DnaK, DnaJ, GrpE and ATP, can bind unfolded MBP but strongly retarded the folding of 
SM-MBP and DM-MBP. On the other hand, the Hsp70 system maintained both SM-MBP 
and DM-MBP competent for further folding by GroEL/GroES (Figure 15B and C). This 
suggests that the acceleration in folding of the mutant MBPs can only occur with the 
GroEL/GroES system. These properties are similar to those recently described for several 
highly aggregation sensitive, authentic GroEL substrates (Kerner et al., 2005).  
To demonstrate that encapsulation of mutant MBP in the GroEL-GroES cage is 
sufficient for accelerated folding, refolding experiments were carried out with the non-
cycling single-ring mutant of GroEL (SR-EL). SR-EL contains four point mutations in 
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Figure 15. Effects of GroEL/GroES on wild-type and mutant MBP refolding. 
(A-F) Refolding of GuHCl-denatured MBP (25 μM) at 25oC upon 100-fold dilution into 
reactions containing either buffer A alone (spontaneous; black), buffer with 0.5 μM GroEL 
or 1.0 μM SR-EL (pink); 0.5 μM GroEL/5 mM ATP or 1.0 μM SR-EL/5 mM ATP (blue); 
0.5 μM GroEL/1 μM GroES/5 mM ATP or 1.0 μM GroEL/2 μM GroES/5 mM ATP (red); 
1.25 μM DnaK/0.625 μM DnaJ/1.25 μM GrpE /5 mM ATP (green); or 1.25 μM DnaK/ 
0.625 μM DnaJ/1.25 μM GrpE /5 mM ATP followed by addition of 0.5 μM GroEL/1 μM 
GroES/5 mM ATP (green circles) at the time indicated by the arrow. The maximum 
recovery of tryptophan fluorescence in the presence of GroEL/GroES/ATP was set to 1 
(~100% of native MBP control). 
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amino acid residues Arg452, Glu461, Ser463 and Val464 that are responsible for the major 
contacts between two rings of GroEL (Weissman et al., 1995). Residue 452 is replaced by 
Glu and the other three residues by Ala. These mutations cause the loss of electrostatic 
interaction between two rings and result in the formation of single heptameric ring 
(Weissman et al., 1996).  SR-EL has previously been shown to fold rhodanese upon binding 
of GroES in the presence of ATP; however, the folded rhodanese was not released from the 
ring cavity since GroES remained associated with SR-EL (Hayer-Hartl et al., 1996; 
Weissman et al., 1996). 
In the presence of GroES and ATP, SR-EL fully reproduced the rate acceleration of 
SM-MBP and DM-MBP folding observed with the cycling GroEL/GroES system, while the 
rate of WT-MBP folding remained unchanged (Figure 15D-F and Supplemental Table 
S1A). Thus, the physical environment of the GroEL-GroES cage is likely responsible for the 
observed increase in folding speed.  
To be certain that the folding rates of MBP measured by intrinsic tryptophan 
fluorescence indeed reflected acquisition of the native state competent in binding maltose; 
we introduced a unique cysteine at position D95 in the N-domain in MBP and MBP mutants 
and labeled them with the fluorophore IANBD. The D95C residue is buried in the absence 
of maltose. Upon maltose binding, MBP undergoes a large conformational change thereby 
D95C residue is exposed and results in a ~2-3 fold fluorescence increase at 538 nm (Marvin 
et al., 1997). Introduction of the D95C mutation slowed the spontaneous refolding of wild-
type and mutant MBP, but very similar folding rates were determined by monitoring 
intrinsic tryptophan or IANBD fluorescence (Supplemental Table S1). As shown in Figure 
16, the folding of MBP followed by D95C-IANBD fluorescence at 538 nm reflects maltose 
binding and hence the native state.  
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Figure 16. Maltose binding of wild-type and mutant MBP.  
Maltose binding of GuHCl-denatured MBP (25 μM) at 25oC upon 100-fold dilution into 
buffer A containing 5 mM maltose alone (blue), buffer with 0.5 μM GroEL/1 μM GroES/5 
mM ATP/ 5 mM maltose (red) or 0.5 μM GroEL/1 μM GroES/5 mM ATP followed by 
addition of 5 mM maltose (green) at the time indicated by the arrow. The maximum 
recovery of IANBD fluorescence in the presence of GroEL/GroES/ATP was set to 1 
(~100% of native MBP control).  
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One other plausible explanation for the accelerated folding rate observed with the 
GroEL and GroES system may be due to the disassembly of small MBP aggregates by 
GroEL in the refolding reactions. We performed refolding experiments with increased 
concentration of  the three MBPs. The folding rates and yields were essentially independent 
of concentration between 50 nM and 1μM for WT-MBP (Ganesh et al., 2001) and the two 
mutant MBPs (Figure 17), arguing against reversible aggregation as the cause of slow 
spontaneous folding of mutant MBP. 
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Figure 17. Folding properties of WT-MBP and MBP mutants 
The concentration titration (50 nM- 2μM) of WT-MBP, SM-MBP and DM-MBP in buffer 
A at 25oC followed by the intrinsic tryptophan fluorescence at 345 nm. 
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Similarly, a chemical crosslinking result also excluded possibility of aggregates formed 
during MBP refolding. Crosslinking reaction by applying DTSSP (3, 3´-dithiobis 
[sulfosuccinimidyl-propionate]) revealed association of MBP monomers during refolding 
can only occurred at protein concentrations above 2 μM (Figure 18), while a control 
reaction carried out in an aggregation-favored environment with 5% Ficoll as crowding 
agent demonstrated the crosslinking procedure is sufficiently sensitive to detect even small 
amount of dimers of MBP. Finally, aggregation of MBP is not observed by 
ultracentrifugation, confirmed again the absence of MBP aggregates in the relevant 
concentration range applied in this work.  
 
 
Figure 18. Folding properties of WT-MBP and MBP mutants. 
GuHCl-denatured WT-MBP was diluted 100-fold into MOPS buffer containing 0.5 mM 
DTSSP. Final concentrations of MBP varied between 0.25- 2 μM. After incubation at 25oC 
for 60 min crosslinking was quenched and samples were analyzed by SDS-PAGE under 
non-reducing conditions followed by silver staining. Control experiment (C) was performed 
with crosslinking of 0.25 μM denatured DM-MBP in 5% Ficoll buffer.  
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4.2. Effects of GroEL cavity size on folding 
As mentioned above, the rate acceleration is GroEL dependent and occurred inside the 
GroEL/GroES cavity. To further understand what the driving forces for accelerated folding 
are, we investigated two major physical properties of the cis chaperonin cage. Firstly, the 
limited volume of cavity and secondly, the hydrophilic properties of the cavity wall. 
 
4.2.1. Properties of GroEL cavity size   
Molecular simulations of the enhancement of the rate of folding of eight small proteins 
inside a cage of various sizes indicated that the ratio of size of protein to the size of the cage 
is important (Takagi et al., 2003). For a 50 kDa polypeptide chain inside the GroEL-GroES 
cage, the predicted rate enhancement is about six-fold, falling to about two-fold for 30 kDa 
protein. These theoretical estimates are in rough agreement with the experimentally 
observed approximate four-fold enhancement for 50 kDa RuBisCo and no enhancement for 
33 kDa Rhodanese folding within the GroEL-GroES cage (Brinker et al., 2001). So, if 
considering that RuBisCo (50 kDa) closely approaches the size limit of the cage (~60 kDa),  
the effect of topological confinement may happen in the GroEL-GroES cage and contribute 
to accelerate folding by increasing the compaction of polypeptide and blocking the 
formation of certain kinetically trapped conformers.  
To explore this possibility, we engineered a series of GroEL mutants with varying 
cavity size. The GroEL subunits contain flexible, C-terminal sequences of 13 residues, 
consisting of 4 Gly-Gly-Met (GGM) repeats and ending with an additional Met residue 
(Figure 19). These [GGM]4M sequences protrude from the equatorial domains into the 
GroEL cavity but are not resolved in the crystal structure (Braig et al., 1994). Deletion or 
extension of these segments afforded the possibility to vary the size of the GroEL-GroES 
cage (Figure 19). Taking the 7-fold symmetry of the structure into account, we estimated 
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that deletion of [GGM]4M, resulting in EL∆C, would increase the volume capacity of 
GroEL for folding intermediates by ~4.4%. In contrast, duplication of the C-terminal 
segment (EL-2[GGM]4) will reduce the volume by ~4.4% compared to WT-GroEL, and the 
mutants EL-3[GGM]4 and EL-4[GGM]4 are expected to have ~91% and 87% of WT-GroEL 
volume, respectively (Figure 19). Additionally, by mutating [GGM]4 to [AAA]4, [GGA]4 or 
2[GGA]4, we changed the size of the cavity in small increments in a manner independent of 
the specific GGM sequence.  
 
 
 
Figure 19. Properties of GroEL cavity size-mutants. 
Schematic representation of a series of GroEL constructs with deletions, mutations or 
extensions in the C-terminal [GGM]4 repeat sequences. The cis-cavity volume of wild-type 
chaperonin was calculated as 161,100 Å3 from the structure of the GroEL-GroES complex , 
taking into account that the N-terminal Met and C-terminal 23 amino acids of GroEL 
(~14,000 Å3) were not resolved in the crystal structure. Volume changes resulting from 
modification of C-terminal segments were estimated based on the known volume of specific 
amino acid residues.  
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These cavity size mutant chaperonins were generated both for GroEL and SR-EL. Upon 
overexpression and purification of these chaperonin mutants in the bacterial strain BL21 
(DE3), we estimate the incorporation of endogenous GroEL is less than 5%, meaning there 
is maximally a single endogenous GroEL subunit assembled in the mutant chaperonin 
complex. Biochemical assays revealed that these purified chaperonins bound unfolded 
protein with similar affinity as WT-GroEL, as evidenced by their ability to inhibit the 
aggregation of rhodanese in the absence of ATP (Figure 20). Surface plasmon resonance 
experiments demonstrated efficient ATP-dependent GroES cycling and stable GroES 
binding in the presence of the non-hydrolysable ATP analog AMP-PNP (or ATP in case of 
non-cycling SR-EL), which indicates that these cavity size mutants are all functional 
chaperonins with regard to their to their substrate binding and ATP/GroES cycling abilities . 
To determine the functional volume capacity of the GroEL mutants, here we applied an 
encapsulation assay which by measuring the degree of protease protection conferred to the 
GroEL-bound substrate protein under GroES in the presence of AMP-PNP. As shown for 
rhodanese (33 kDa), DM-MBP (41 kDa) and bacterial RuBisCo (50 kDa), GroEL-bound 
protein was rapidly degraded in the absence of GroES (Figure 21A). Addition of GroES to 
WT-GroEL resulted in ~50% protection of substrate, as expected due to the asymmetrical 
binding of GroES (Figure 21B) (Hayer-Hartl et al., 1996). While a similar degree of 
protection was observed with EL∆C, EL-[AAA]4 and EL-[GGA]4. However, the stepwise 
extension of the [GGM]4M segment resulted in a reduced capacity of protein encapsulation. 
This effect was most pronounced with the largest protein RuBisCo. For example, while EL-
4[GGM]4 , having a ~13% reduced cavity volume, allowed efficient encapsulation of 
rhodanese, encapsulation of DM-MBP and RuBisCo was reduced by 40% and 90%, 
respectively (Figure 21A and B). Similar results were obtained with the cavity size-mutants 
of SR-EL (Figure 22). 
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Figure 20.  Inhibition of rhodanese aggregation by GroEL and SR cavity size 
mutants. 
Rhodanese (25 μM) was denatured in 6M GuHCl and 100-fold dilution into buffer without 
(Spon) or with presence of chaperones as indicated for either GroEL (0.5 μM, A) or SR-EL 
(1μM, B). Aggregation was monitored by spectrophotometer at 320nM and the absorbance 
value of spontaneous experiment after 10min was set to 1.   
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Figure 21.  Proteinase K protection of GroEL- GroES- substrate complex. 
(A) Proteinase K (PK) protection of rhodanese (250 nM), DM-MBP (250 nM) or RuBisCo 
(250 nM) bound to WT-GroEL or GroEL cavity size mutants (0.5 μM). GroEL-substrate 
complexes were incubated with PK (2 μg/ml) in buffer A containing 4 mM AMP-PNP in 
the absence or presence of GroES (1 μM) at 25oC. (B) Protected substrate protein was 
quantified by immunoblotting and densitometry. Amounts in non-protease treated reactions 
correspond to 100%.  
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Figure 22.  Proteinase K protection of SREL- GroES- substrate complex. 
(A) Proteinase K (PK) protection of rhodanese (250 nM) or DM-MBP (250 nM) bound to 
SREL or SR cavity size mutants (1 μM). SREL-substrate complexes were incubated with 
PK (2 μg/ml) in buffer B containing 4 mM AMP-PNP in the absence or presence of GroES 
(2 μM) at 25oC. (B) Protected substrate protein was quantified by immunoblotting and 
densitometry. Amounts in non-protease treated reactions correspond to 100%.  
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4.2.2. Effects of GroEL cavity size on folding  
We next investigated how changing the size of the GroEL cavity affected the folding 
rates of proteins differing in molar mass, including mutant MBP (41 kDa) and the GroEL-
dependent substrates rhodanese (33 kDa), MetF (33 kDa) and RuBisCo (50 kDa). 
Importantly, these experiments were performed with 500 nM substrates refolding at 25oC, 
which is non-permissive, namely, no spontaneous refolding detectable for rhodanese, MetF 
and RuBisCo due to aggregation, except for MBP. 
Dependent on protein size, optimal folding rates were either observed with normal sized 
cavity or upon reduction of cage volume in both double ring and single ring chaperonin 
(Figure 23 and Figure 24). Deletion of [GGM]4M (EL∆C), expanding the GroEL cis cavity 
by ~4.4%, generally reduced folding speed without changing the folding yields (Figure 23 
and Figure 25). Strikingly, reducing wild-type cavity size by ~1.9, 3.1 and 4.4% in 
constructs EL-2[GGA]4, EL-[GGA]4 [GGM]4 and EL-2[GGM]4, respectively, resulted in a 
highly reproducible, stepwise enhancement of folding rate for rhodanese and MetF (Figure 
23A and B). This effect correlated well with the decrease in available cage volume of the 
GroEL mutants. Notably, it was independent of the hydrophobic Met residues in the C-
terminal extensions, and was therefore attributed to spatial confinement rather than to 
specific interactions with the extended GroEL sequences. Further reduction of cavity size 
(EL-3[GGM]4) reversed the rate acceleration without affecting the folding yield. Finally, 
very slow folding rate was observed with EL-4[GGM]4 (Figure 23A and B), accompanied 
by a 40-70% reduction in folding yield (Figure 25). Because encapsulation of rhodanese by 
GroES was still fully efficient (Figure 21), this indicates that the restriction in space may 
have limited critical rearrangement steps during folding.  
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Figure 23.  Effect of GroEL cavity size on folding rates. 
GroEL/GroES assisted refolding of rhodanese (A), MetF (B), SM-MBP (C), DM-MBP (D-
E) and RuBisCo (F) at 25oC with the GroEL mutants indicated. Blue bars, cavity size 
mutants (decreasing cavity size from left to right); light gray bars, mutants with reduced 
hydrophobic character of the C-terminal repeat sequences. The refolding rate obtained with 
WT-GroEL (red bar) was set to 1. The dashed line represents the rate of spontaneous folding 
for MBP. Representative tryptophan fluorescence folding traces for DM-MBP are shown in 
(E). Standard deviations of at least three independent experiments are shown. 
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The accelerated folding of rhodanese found for EL-2[GGM]4 can be recapitulated with 
the non-cycling single ring chaperonin SR-2[GGM]4. And interestingly, other cavity size 
mutants in SR followed essentially the same trend of change for folding speed, indicating 
the space confinement contributed evidently to the enhancement of folding rate, thus 
implied the ATP-driven cycling for substrates is dispensable for this increase-of-rate finding 
(Figure 24).     
In contrast to rhodanese and MetF, reducing cavity size did not accelerate folding for 
the larger protein MBP. While EL-2[GGM]4 still supported folding of SM-MBP at the rate 
similar to WT-GroEL, interestingly, the folding speed of DM-MBP was ~40% reduced, 
suggesting that the folding pathways of the mutant proteins differ (Figure 23C-E). Further 
reduction in cavity size (EL-3[GGM]4) slowed the folding of both proteins without reducing 
the folding yield (Figure 23C, D and Figure 25), although encapsulation by GroES was still 
~70% efficient (Figure 21). Again, comparable folding rates and yields of DM-MBP were 
observed in SR cavity size mutants suggested the result is independent of multiple rounds of 
folding cycles (Figure 24 and Figure 25).  
Additionally, changing the [GGM]4 sequence to [AAA]4, [GGA]4 and [GGA]4[GGM]4 
all affected the folding speed of MBP, implying a sequence specific effect of [GGM]4M 
may contribute to the organization of MBP folding intermediates in the cis cavity. A 
sequence-specific effect of [GGM]4M on folding will be discussed below in 4.2.3.  
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Figure 24.  Effect of SR-EL cavity size on folding rates. 
SR-EL/GroES assisted refolding of rhodanese (A), and DM-MBP (B) at 25oC with the SR-
EL mutants indicated. Blue bars, cavity size mutants (decreasing cavity size from left to 
right); light gray bars, mutants with reduced hydrophobic character of the C-terminal repeat 
sequences. The refolding rate obtained with SR-EL (red bar) was set to 1. Standard 
deviations of at least three independent experiments are shown. 
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Figure 25. Refolding yields observed for the various GroEL cavity size constructs. 
Refolding yields of rhodanese, MetF, SM-MBP, DM-MBP and RuBisCo in the refolding 
assays from Figure 23 (Panel A, double ring chaperonin) and Figure 24 (Panel B, single ring 
chaperonin). White bars indicate cavity size mutants (decreasing cavity size from left to 
right) and the light gray bars indicate constructs that modulate the mildly hydrophobic 
character of the C-terminal repeat sequence. The refolding yield obtained with WT-GroEL 
or SR-EL (black bar) was set to 1. 
 
 
Consistent with its larger size, the folding of RuBisCo was even more strongly affected 
by decreasing the volume of the chaperonin cage (Figure 23F). This effect was independent 
of the specific sequence of the C-terminal extension, because both EL-[AAA]4 and EL- 
shown similar capacities in folding RuBisCo as GroEL wild-type. And, along with 
observation, EL-2[GGA]4 and EL-2[GGM]4 equally slowed RuBisCo folding to ~15% 
without affecting the yield (Figure 23 and Figure 25). In contrast, the folding yield was 
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reduced by ~50% with EL-3[GGM]4 and by ~95% with EL-4[GGM]4, correlating with the 
loss of encapsulation (see Figure 21).  
Fluorescence anisotropy measurements using the D95C variants of mutant MBP labeled 
with Alexa 488 confirmed the idea that reducing cavity size restricted the mobility of 
enclosed protein. To ensure the result is obtained with single binding step the chaperonin 
instead of binding-release cycle between the bulk and the chaperonin, these experiments 
were performed with the non-cycling SR-EL cavity size-mutants. When bound denatured 
MBP to the apical domains of SR-EL, the anisotropy value of the unfolded protein was 
high, reflecting the low rotational dynamics of the large SR-EL-substrate complex (Figure 
26A and B). Upon GroES binding triggered by ATP addition, a rapid drop in anisotropy 
occurred, indicating increased dynamics resulting from displacement of the bound protein 
into the cage (Rye et al., 1997). For SM-MBP in SR-EL or SR-2[GGM]4, this step was 
followed by a time-dependent increase in mobility occurring with kinetics corresponding to 
folding, as measured by tryptophan fluorescence (Figure 26A). In contrast, the folding 
protein was increasingly restricted in mobility in SR-3[GGM]4 and SR-4[GGM]4 (Figure 
26A). DM-MBP generally experienced a more pronounced restriction in mobility (Figure 
26B), suggesting that this protein populates more extended folding intermediates. 
These results are consistent with theoretical simulations of the effects of steric 
confinement on protein folding (Baumketner et al., 2003; Takagi et al., 2003; Zhou, 2004), 
which predict that proteins will experience a rate acceleration of folding with increasing 
confinement up to a point where further restriction in space would limit necessary 
reconfiguration steps.  
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Figure 26. Restriction in substrate protein mobility upon encapsulation in SR-EL 
and in SR-EL with mutated C-terminal sequences. 
Kinetics of steady state fluorescence anisotropy of SM-MBP (A) and DM-MBP (B) upon 
encapsulation by GroES in the SR-EL cavity size-mutants indicated. D95C versions of MBP 
were labeled with Alexa 488 (see Experimental Procedures). GroES binding was initiated 
by addition of ATP (arrow). Note that removal of non-encapsulated DM-MBP by proteinase 
K in the reaction with SR-4[GGM]4 in (B) had only a small effect on anisotropy, indicating 
that largely encapsulated protein was measured (see inset).  
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4.2.3. Function of GGM repeats in folding   
The flexible, mildly hydrophobic GGM repeats of GroEL are highly conserved among 
GroEL homologs from different species (Brocchieri and Karlin, 2000). GroEL lacking this 
sequence was found to support the growth of E. coli but in contrast to WT-GroEL was 
unable to suppress temperature sensitive mutations of chromosomal replication initiator 
protein dnaA (McLennan et al., 1993). We found that changing [GGM]4M to [AAA]4A or 
[GGA]4A decelerated the folding of mutant MBP to a greater extent than deleting [GGM]4M 
altogether (Figure 23C and D). Anisotropy measurements revealed that, contrary to 
expectations, increasing cavity size by deleting [GGM]4M (SR∆C) did not increase protein 
mobility during folding (Figure 26A and B). Moreover, replacement of [GGM]4M by 
[AAA]4A caused a substantial restriction in mobility of the folding protein, an effect that 
was again most pronounced with DM-MBP and was not seen with WT-MBP (Figure 26B). 
Notably, these mutations had only a small effect on the folding of rhodanese, MetF and 
RuBisCo (Figure 23A, B, F). Similarly, mutants EL-2[GGA]4 and EL-[GGA]4[GGM]4 were 
less effective than EL-2[GGM]4 in the folding of mutant MBP (Figure 23C and D). These 
results argue for a specific role of [GGM]4 in facilitating the rearrangement of certain 
folding intermediates by providing a mildly hydrophobic, interactive surface. This function 
may be particularly important for proteins which have acquired mutations that result in 
highly energetically frustrated folding pathways, such as the mutant versions of MBP. 
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4.3. Role of negative charge clusters on the cavity wall in 
GroEL assisted folding  
4.3.1. GroEL mutants with altered cavity charge    
The wall of the GroEL cis cavity has a net charge of minus 42 (189 negatively and 147 
positively charged amino acid residues). A number of negative charges (residues E252, 
D253, E255, D359, D361, and E363), which are all positioned in the apical domain, cluster 
in two circular layers (Figure 27). Most of these residues (E252, D253, E255, E363) are 
highly conserved among GroEL homologs, although they have no apparent role in the basic 
GroEL functions of substrate and GroES binding (Brocchieri and Karlin, 2000; Stan et al., 
2003). To explore their possible significance in promoting folding, we replaced individual 
or multiple residues by either asparagine or glutamine (neutral) or lysine (positive) in SR-
EL, in attempt to demonstrate the effect in a non-substrate-cycling manner. As a 
consequence of the 7-fold symmetry of GroEL, these mutations dramatically change the 
electrostatic character of the cavity wall (Figure 27). The mutant proteins were efficiently 
overexpressed and purified in soluble form and have been verified on blue native gels as 
heptamer. All the SR-EL charge-mutants bound GroES stably in the presence of ATP, 
reflecting the inability of SR-EL to cycle GroES. Binding of GroES to preformed complexes 
of mutant SR-EL and unfolded DM-MBP resulted in 90-100% protease protection (Figure 
28). In contrast, several of the SR-EL charge mutants, such as SR-QNQ, SR-3N3Q and SR-
D359K had a 40-50% reduced capacity to support RuBisCo encapsulation, suggesting an 
interference with the compaction of the molecule normally occurring upon its displacement 
into the cage by GroES (Lin and Rye, 2004). A ~75% reduced encapsulation efficiency was 
observed with mutation D253K (Figure 28). This mutant was not analyzed further with 
regard to RuBisCo folding.  
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Figure 27. Properties of GroEL cavity charge-mutants. 
Space-filling model of GroEL/GroES-(ADP)7 complex (, pdb 1AON, DS ViewerPro) 
offering a view into the cis-cavity with 4 subunits of GroEL and GroES shown. Clusters of 
negatively charged residues exposed towards the cis-cavity are highlighted in red (E252, 
D253, E255) and blue (D359, D361, E363). The net charge of the cis-cavity wall formed by 
7 GroEL subunits is indicated for the different mutants.  
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Figure 28. Proteinase K protection of SREL- GroES- substrate complex. 
(A) PK protection of rhodanese, DM-MBP and RuBisCo in complexes with the various 
mutant forms of SR-EL and GroES. PK treatment was performed as in Figure 21. SREL-
substrate complexes were incubated with PK (2 μg/ml) in buffer A/4 mM AMP-PNP in the 
absence or presence of GroES at 25oC. (B) Protected substrate protein was quantified by 
immunoblotting and densitometry. Amounts in non-protease treated reactions correspond to 
100%.  
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4.3.2. Effects of GroEL cavity charge on folding  
The charge mutations were without effect on the rate or yield of WT-MBP folding, but 
moderately reduced the folding speed of SM-MBP and markedly decelerated DM-MBP 
folding (Figure 29A-C and Figure 30). Changing single or multiple negative charges to 
neutral residues slowed DM-MBP folding by 30 to 80%, with multiple mutations generally 
having a more severe effect (Figure 29C). The effects of replacing negative with positively 
charged residues varied considerably dependent on the specific protein tested. For example, 
the single charge reversal of SR-D359K, while strongly decelerating the folding of DM-
MBP, caused a moderate acceleration of rhodanese folding and was without effect on the 
folding rate of RuBisCo (Figure 29 C and D). In the case of RuBisCo, some of the charge 
mutants strongly diminished the folding yield. An interesting example is SR-NNQ, which 
caused an 80% reduction in yield (Figure 30), although the protein was efficiently 
encapsulated by GroES (Figure 28). However, the subpopulation of molecules that reached 
native state did so with almost the normal rate as for SR-EL (Figure 29D). This indicated 
that a large fraction of RuBisCo was trapped inside the SR-NNQ-GroES cage in a non-
native state. A virtually complete folding arrest of encapsulated RuBisCo was observed with 
SR-KKK(2), containing positive charges at positions D359, D361 and E363. Indeed, upon 
dissociation of GroES at low temperature in the presence of EDTA, most of the RuBisCo 
was released from the cavity in a PK-sensitive, non-native state. In contrast, PK-resistant, 
folded protein was detected when the same experiment was carried out with wild-type SR-
EL. The complete removal of cavity net charge in SR-KKK(2) also strongly decelerated the 
folding of DM-MBP, but caused a moderate increase in folding speed for rhodanese (Figure 
29C and D). It is noteworthy in this context that WT-MBP and RuBisCo have a negative net 
charge of -8 and -11, respectively, whereas rhodanese, the protein least affected by the 
charge mutations, has a net charge of only -1 (Supplemental Table S2). The correlation of 
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interaction strength between substrate net charge and GroEL cage charge composes an 
interesting subject that remaines to be studied further.   
 
 
 
Figure 29. Effect of GroEL cavity charge on folding rates. 
Refolding of WT-MBP (A), SM-MBP (B), DM-MBP (C), rhodanese and RuBisCo (D) with 
the indicated SR-EL charge mutants and GroES was analyzed in buffer B/5 mM ATP at 
25oC as described in Experimental Procedures. White bars indicate amino acid changes 
from negative to neutral and light gray bars changes from negative to positive. The refolding 
rate obtained with SR-EL was set to 1 (black bar). Dashed line represents the rate of 
spontaneous folding for the respective proteins. 
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Figure 30. Refolding yields observed for the various SR-EL charge constructs 
Refolding yields of WT-MBP, SM-MBP, DM-MBP, RuBisCo and rhodanese of the 
refolding assays from Figure 29. The white bars indicate negative to neutral amino acid 
changes, and the light gray bars are negative to positive amino acid changes. The refolding 
yield obtained with SR-EL was set to 1 (black bar). 
 
Reducing the negative net charge of the cavity wall strongly impaired the mobility of 
MBP in the chaperonin cage. This effect was already apparent with the D95C version of 
WT-MBP (Figure 31A). The protein interacted substantially with the less negatively 
charged cavity wall, both during folding and after reaching native state. Further, mobility 
was even more restricted with the slower folding SM-MBP and DM-MBP (Figure 31B and 
C). Mutants which caused complete loss of cavity wall net charge, such as SR-3N3Q and 
SR-KKK(2) (see Figure 27), significantly slowed the rapid mobilization of SM-MBP and 
DM-MBP normally occurring immediately upon GroES binding (Figure 31B and C). This 
suggests that the non-native states of these proteins interact with the cavity wall 
immediately after release from the apical GroEL domains, presumably resulting in delayed 
burial of hydrophobic residues.  
These findings indicate that the charge properties of the GroEL cavity wall are of 
profound significance in the ability of the chaperonin to promote the folding of certain 
substrate proteins. While the charge effects on specific proteins may vary, the overall 
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negative surface charge of the cavity wall of the apical domains appears to provide a non-
interactive surface optimized to accomplish the efficient folding of many different proteins. 
 
Figure 31. Restriction in substrate protein mobility upon encapsulation in SR-EL 
and SR-EL cavity charge mutants. 
Kinetics of steady state fluorescence anisotropy of WT-MBP (A), SM-MBP (B) and DM-
MBP (C) upon encapsulation by GroES in the SR-EL cavity charge mutants indicated. 
D95C versions of MBP were labeled with Alexa 488 (see Experimental Procedures). GroES 
binding was initiated by addition of ATP (arrow). 
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4.4. Study GroEL/GroES assisted folding in vivo  
4.4.1. Significance of accelerated folding by GroEL/GroES in vivo  
The requirement of GroEL/GroES for efficient protein folding in vivo is well 
established, but it is unclear whether the capacity of the chaperonin to accelerate folding is 
biologically relevant. We addressed this question by using our model substrate MBP and a 
recently identified in vivo substrate of GroEL, MetF. Overexpression of WT-MBP from an 
arabinose controlled expression plasmid in E. coli resulted in the production of fully soluble 
protein. In contrast, expression of SM-MBP, DM-MBP and MetF produced largely 
insoluble protein (Figure 32A). Additional overexpression of GroEL/GroES, but not of 
GroEL alone, dramatically reduced the formation of aggregates and allowed the production 
of soluble protein (Figure 32B and C). Overexpression of EL∆C suppressed the aggregation 
of SM-MBP, DM-MBP and MetF only partially (Figure 32D), consistent with the reduced 
folding rates observed with EL∆C in vitro (Figure 23B-D). Expression of the GroEL variant 
with reduced cavity size, EL-2[GGM]4, resulted in a similar effect in the case of mutant 
MBP, but allowed the production of soluble MetF with close to 100% yield (Figure 32E). 
This enhancement of solubility corresponds with the accelerated folding of MetF by EL-
2[GGM]4 observed in vitro (Figure 23B-D). As expected, EL-4[GGM]4 was unable to 
support the folding of mutant MBP or MetF (Figure 32F). Changing the repeat motif from 
[GGM]4M to [GGA]4A failed to produce significant amounts of native mutant MBP but 
only partially suppressed the aggregation of MetF (Figure 32G), confirming the sequence-
specific contribution of [GGM]4M to mutant MBP folding (Figure 23C and D). Similarly, 
the charge mutants EL-NNQ, EL-3N3Q and EL-KKK(2), while partially efficient in MetF 
folding, markedly reduced the amount of soluble mutant MBP (Figure 32H-J), again 
consistent with the observations in vitro (Figure 29B-C). Collectively, these results 
demonstrate the biological relevance of accelerated folding achieved by the chaperonin 
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system. Reducing the ability of GroEL to accelerate folding diminishes its capacity to 
handle recalcitrant proteins such as the mutant versions of MBP. On the other hand, 
decreasing the size of the GroEL cavity is beneficial for the folding of the smaller protein, 
MetF. 
 
4.4.2. GroEL depletion strain 
To further address the functional relevance of these GroEL variants in vivo, we assayed 
for growth complementation of WT-GroEL. Since GroEL is essential under all conditions 
for the viability of E. coli (Fayet et al., 1989), we used a special E. coli strain, MC4100 
SC3, in which the groE operon is under the control of the arabinose promoter. Endogenous 
GroEL and GroES expression is therefore critically dependent on the presence of  arabinose 
in the growth medium (Kerner et al., 2005 and Figure 30). Control tests with empty vector 
or only GroEL overexpression failed to complement for the growth of this strain, supporting 
previous findings that both GroES and GroEL are non-dispensable for growth. Interestingly, 
gradually shrinking the cage size resulted in a loss of complementation ability of ~10 times 
and ~1,000 times for EL-3[GGM]4 and EL-4[GGM]4, respectively (Figure 33). This is 
probably due to the consequence of failure to fold obligate substrates of GroEL in the small 
cage, correlating well with the in vitro refolding and in vivo co-expression experiments on 
MetF (Figure 23 and Figure 32). Similarly, strong impairment in growth with the cavity 
charge mutants like EL-3N3Q and EL-KKK(2) also suggested the significance of surface 
property of the GroEL/GroES cis-cage can contribute to the protein folding.  
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Figure 32. Effect of WT-GroEL and GroEL mutants on folding in vivo.  
WT-MBP, SM-MBP, DM-MBP or MetF were overexpressed in E. coli cells of strain 
MC4100C either without (A) or with additional overexpression of GroES and the GroEL 
mutants indicated (C-J). GroES expression was omitted in (B). Total (T), supernatant (S) 
and pellet (P) fractions were analyzed by SDS-PAGE and Coomassie staining. Amounts of 
MBP or MetF protein in S and P fractions, determined by densitometry, are given in % with 
total protein (T) set to 100%. The asterisk indicates the position of MBP or MetF. 
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Figure 33.  Complementation effect of GroEL size and charge mutants in EL/ES-
depletion stain.  
Spectinomycin-resistant constructs encoding denoted genes were transformed into E. coli 
MC4100 SC3 cells (Kerner et al., 2005) and grew with either wild-type GroEL/GroES 
induction (left, 0.05% arabinose) or engineered GroEL induction (right, 0.1 mM IPTG) on 
LB plates. Serial dilutions were performed according to Experimental Procedures.    
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5. Discussion 
The GroEL/GroES nano-cage allows a single protein molecule to fold in isolation. This 
reaction has been compared to spontaneous folding at infinite dilution. However, recent 
theoretical studies indicated that the physical environment of the chaperonin cage can alter 
the folding energy landscape, resulting in accelerated folding for some proteins (Takagi et 
al., 2003; Zhou, 2004). This suggested that GroEL/GroES has a role in folding beyond 
providing an infinite dilution box. 
By performing an extensive mutational analysis of GroEL, we have identified three 
structural features of the chaperonin cage as major contributors to this capacity: i) geometric 
confinement exerted on the folding protein inside the limited volume of the cage, ii) a 
mildly hydrophobic, interactive surface at the bottom of the cage, and iii) clusters of 
negatively charged amino acid residues exposed on the cavity wall. We suggest that these 
features in combination provide a physical environment that has been optimized in evolution 
to catalyze the structural annealing of proteins with kinetically complex folding pathways. 
Thus, the chaperonin system and its mutant versions may prove as useful tools in 
understanding how proteins navigate their energy landscape of folding.  
 
5.1. Effect of spatial confinement on folding rate  
Initial experimental observations by Brinker et al., (2001) demonstrated an acceleration 
effect of GroEL on the folding rate. The conditions for an efficient renaturation of R. 
rubrum RuBisCo in vitro were elaborated, and a comparative study was performed. This 
result showed that the folding of RuBisCo inside the GroEL-GroES cavity was four times 
faster than spontaneous folding in bulk solutions, suggesting a catalytic role of the GroEL-
GroES system. Since the non-cycling SR-EL mutant could reproduce the rate acceleration 
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of the folding of RuBisCo, this indicated that the rate acceleration in the GroEL cavity is 
unrelated to repeated cycles of binding and release. The fact that similar experiments carried 
out with another substrate protein, rhodanese, whose molecular weight (~33 kDa) is 
considerably lower than RuBisCo (~50 kDa), revealed no acceleration effect by GroEL, 
suggested that this acceleration effect may be dependent on the size of the substrate protein 
relative to the dimensions of the central cavity. 
In the crystal structure, the GroEL-GroES cage has a volume of ~175,000 Å3, in 
principle large enough to accommodate proteins of >70 kDa (Xu et al., 1997). However, the 
functionally relevant volume is smaller, due to the C-terminal 23 amino acids of the GroEL 
subunits, which protrude into the cavity but are not resolved in the structure. Because of 
their flexible character, these segments are likely to occupy more than their nominal volume 
of ~14,000 Å3 per GroEL ring. Moreover, since the geometry of the cage resembles a 
truncated cone, part of the volume may be unavailable to certain substrate proteins. 
Consistent with these considerations, most GroEL-dependent proteins are smaller than 50 
kDa (Kerner et al., 2005) and the 56 kDa phage T4 capsid protein, Gp23, already requires 
an enlarged, phage-encoded version of GroES (Gp31) for encapsulation (Bakkes et al., 
2005; Hunt et al., 1997). It follows that a typical GroEL substrate would undergo 
considerable compaction upon displacement into the cage from a loosely packed bound state 
(Horst et al., 2005). This step is mediated by ATP and GroES binding, which drive large 
allosteric domain movements in GroEL (Figure 11).  
Confinement of a protein within a cavity might prevent formation of non-native 
conformations possessing radii of gyration larger than the radius of the enclosing cavity. 
And an enclosed substrate protein should demonstrate a significantly higher stability 
compared to bulk solution, because unfolded states with expanded volume will be 
disallowed in bulk, which increased the risk of incorrect compaction or aggregation 
(Thirumalai et al., 2003). In support of this hypothesis, a range of computational studies 
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(Takagi et al., 2003; Zhou, 2004), as well as experimental observations on protein confined 
within silica glass nanopores (Eggers and Valentine, 2001), have shown that spatial 
confinement of a protein can, in fact, lead to a large increase in protein stability. More 
significantly, however, the spatial restriction of a non-native folding intermediate could 
have a profound effect on the kinetics and mechanism of folding. The experimental 
observation of accelerated RuBisCo folding inside the GroEL-GroES cavity suggested that 
the folding landscape of a protein can be fundamentally altered by encapsulation (Brinker et 
al., 2001). Several computational studies using lattice and molecular dynamics simulation 
models have also provided support for this conclusion (Baumketner et al., 2003; Takagi et 
al., 2003; Xu et al., 2005; Zhou, 2004).  
The geometric confinement exerted by the cage would result in a destabilization of 
unfolded conformers relative to bulk solution and in the preferential population of compact 
intermediates, thus potentially smoothing rugged folding energy landscapes and enhancing 
the folding rate (Figure 34) (Baumketner et al., 2003; Brinker et al., 2001; Takagi et al., 
2003; Zhou, 2004). Because the entropic penalty for establishing long-range interactions is 
large, the acceleration of folding is predicted to be more pronounced for proteins with a high 
proportion of long-range tertiary contacts (Takagi et al., 2003), such as the GroEL-
dependent proteins with complex α/β or α+β domain topologies (Kerner et al., 2005).  
We have performed the first systematic test of these ideas by gradually reducing or 
increasing the volume of the chaperonin cage. The results of these experiments are 
remarkably consistent with prediction. Relatively small proteins such as rhodanese and 
MetF (33 kDa) experienced a rate acceleration of folding upon reducing cage size to a point 
where further restriction in space slowed folding dramatically. For MBP (41 kDa) and 
RuBisCo (50 kDa), on the other hand, either reducing or increasing cage volume decelerated 
folding, indicating that WT-GroEL provides an optimal level of spatial confinement for 
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these proteins. The optimum for productive confinement proved to be remarkably narrow, 
with as little as 2-5% change in cage volume affecting folding rates by 2-fold or more.  
On the other hand, “over-confinement” may stabilize misfolded states that require 
substantial expansion in order to return to a productive folding trajectory. Taking the 
geometries of cage and substrate proteins into consideration, the extent of conformational 
movement possible during folding is indeed very limited. For rhodanese, MetF and MBP, 
the longest axes of the native proteins are between 60-73 Å, compared to 85 Å as the longest 
dimension of the cage (Supplemental Table S2). Remarkably, in the case of RuBisCo, the 
long axis of the native monomer is 95 Å, suggesting either that the GroEL-GroES complex 
is conformationally plastic or the product of RuBisCo folding is a compressed monomer. 
The latter possibility would be consistent with recent FRET measurements for this protein 
when enclosed in the GroEL-GroES cage (Lin and Rye, 2004). 
 
Figure 34. The mechanism of GroEL-GroES accelerated folding .  
Simple energy diagrams are shown for (Left) Spontaneous folding. Unfolded protein 
partitions between a fast pathway to the native state and preferred formation of a trapped 
intermediate whose spontaneous conversion to the native state is slow. (Right) Accelerated 
chaperonin-assisted folding as a result of confinement. Formation (or accumulation) of 
trapped intermediate is thought to be avoided in the confined environment of the chaperonin 
cage. This is reflected in a smoothing of the energy surface (red line). In this model, the 
energy of ATP is utilized to discharge unfolded protein into the narrow hydrophilic space of 
the chaperonin cage. From Brinker et al. (2001) 
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5.2. Effect of the mildly hydrophobic C-terminal GGM repeat 
on folding rate  
The amino acid sequences of all members of the Group I chaperonin, including GroEL, 
share a striking motif located at the C-terminus. This motif, variable in length and exact 
sequence, consists mainly of glycine and methionine residue. The GGM repeats are also 
observed in other ATPase protein families, like Hsp70 (Karlin and Brocchieri, 1998) or 
RecA (Brendel et al., 1997). The significance of these repetitive elements is unknown. This 
motif in Hsp70 was suggested to react with the Hsp70 peptide binding site, leading to 
Hsp70 oligomer formation (Rippmann et al., 1991). In other glycine-rich protein, keratins, 
the glycine-rich motifs are organized into loops in which the hydrophobic residues (i.e. 
methionines) stack and the flexible structure is akin to a molecular spring. However its 
function in the GroEL cis cage may be different and profound. Molecular dynamics 
simulations of the folding of a highly energetically frustrated protein inside the chaperonin 
cage suggested that a moderately hydrophobic wall would accelerate folding substantially 
(Jewett et al., 2004). The mildly hydrophobic GGM repeats may fulfill such a role, perhaps 
by intercalating between hydrophobic regions of folding intermediates, thereby preventing 
the formation of kinetically stable, misfolded states. This GGM repeat-substrate interaction 
maybe in particularly important for certain substrates, as revealed from the folding 
experiments. When changing the GGM repeat to AAA or GGA repeats, with little change in 
the relative size of the cage, both SM-MBP and DM-MBP displayed impaired folding rates, 
and RuBisCo was mildly affected, in the mutated cavities (Figure 23). The anisotropy 
measurement for MBP mobility upon encapsulation implied that such a slight 
hydrophobicity change of the cage bottom can affect the rearrangement of folding 
intermediates as much as the over-confined environment of EL-3[GGM]4 (Figure 26). 
Summary 99 
Taken together with the confinement effect results, our data support a model in which 
the bimodal character of the cavity wall facilitates the re-configuration of folding 
intermediates within the confined cage. Notably, the resulting annealing mechanism is 
independent of repeated cycles of active GroES and ATP-dependent unfolding, in contrast 
to the “iterative annealing” model (Thirumalai and Lorimer, 2001). Instead, “cage-mediated 
annealing” would achieve a smoothing of the folding energy landscape in a single 
encapsulation cycle by sequestrating the protein in a confined space with an optimized 
mixture of a hydrophobic foundation property. Consistent with this proposal, changes in 
these properties had the most pronounced effect on the folding of DM-MBP and RuBisCo, 
those proteins in the test set which experienced the highest enhancement in folding rate by 
GroEL.  
 
5.3. Physical properties of the GroEL cavity wall  
In theoretical models of confinement, proteins are generally assumed to be enclosed in a 
volume limited by an inert, repulsive wall. Our mutational analysis demonstrates that polar 
and hydrophobic wall properties of the chaperonin cage, acting in conjunction with 
geometric confinement, contribute critically to the ability of the system to accelerate 
folding. As known charge allows versatile ways of interactions, from weak to strong 
between molecules, the highly conserved charged residues lining the central cavity of the 
GroEL is likely to be necessary for the reconfiguration of the misfolded or partially 
unfolded proteins into their native conformations, by providing a strong hydrophilic 
environment that compels formation of the hydrophobic core. This electrostatic repulsion 
effects is a mechanism frequently happens for rapid and long-range effects that help orient 
the surface, as well as facilitating hydrophobic interactions. Additionally, given that most 
GroEL substrates have a negative net charge (Kerner et al., 2005), the electrostatic repulsion 
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force may also contribute to repel the substrate from the GroEL cavity wall upon succeeding 
with its folding (Hunt et al., 1997; Wang et al., 2002).  
In fact, substrate intermediate and the cavity wall would most likely accommodate no 
more than a thin hydration layer around the exterior of the substrate protein. As even 
demonstrated for native and well folded proteins of modest size, like GFP (~27 kDa), 
confinement within the GroEL-GroES cavity appears to impose serious constrains on the 
rotational freedom of the protein. The rotational correlation time of native GFP enclosed 
within the SR-EL/GroES cavity was found to be 4-fold slower than in free solution 
(Weissman et al., 1996). This suggests either significant, direct interactions between native 
GFP protein and the walls of the GroEL cavity, or a considerable increase in the effective 
viscosity of the hydration layer between the GFP and SR-GroES cavity wall that all because 
of the charge-mediated electrostatic force. For much larger substrate protein, like RuBisCo, 
the extent of physical constriction is likely to be far more significant. Indeed, the average 
hydration layer between a marginally expanded and large folding intermediate and the 
cavity wall might be no thicker than a single water molecule (Thirumalai and Lorimer, 
2001).   
   
5.4. Biological relevance of cage-mediate annealing  
Based on the recent analysis of the GroEL substrate proteome, ~ 85 E. coli cytoplasmic 
proteins are predicted to be strictly dependent on GroEL/GroES for folding, including 13 
proteins with essential functions (Kerner et al., 2005). It would appear that the chaperonin 
cage has been optimized to accomplish the folding of these proteins at a biologically 
relevant time scale. As noted previously, the properties of the cage must therefore represent 
an evolutionary compromise to support a variety of folding pathways (Wang et al., 2002), 
and this would explain why mutating certain features may improve the folding of a specific 
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protein while potentially being detrimental to the folding of others. However, significant 
structural deviations may be tolerated when additional, specialized forms of GroEL are 
expressed to allow adaptation of an organism to specific growth conditions. Interestingly, 
Mycobacteria express two forms of GroEL, of which GroEL1 lacks the C-terminal GGM 
repeat and instead has an 18 amino acid, histidine-rich sequence. This C-terminal sequence 
appears to be critical for GroEL1 to support the folding of proteins required for bacterial 
biofilm formation (Ojha et al., 2005). 
An additional important role of cage-mediated annealing is to preserve the foldability of 
a protein despite the presence of mutations, as shown for mutant MBP. This capacity would 
explain the recent finding that overproduction of GroEL/GroES reduces the phenotypic 
penetrance of deleterious mutations in bacterial cell lineages (Maisnier-Patin et al., 2005), in 
a manner comparable to the conformational buffering effects proposed for other chaperone 
systems (Rutherford and Lindquist, 1998).  
Overall, the size and surface properties of the cage represent an evolutionary 
compromise that helps the bacterial cell to produce functional proteins fast enough to 
survive in a competitive microbial world. 
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5.5. Perspectives  
With this new view of chaperonin-assisted folding we may need to reconsider several 
issues in protein folding. Are the intermediates of folding within the GroEL/GroES cavity 
different from the intermediates formed during spontaneous folding?  Are new, more 
efficient routes for folding opened up by the special cavity environment? How can we 
exploit knowledge of chaperonin structure and function to enhance the folding of “difficult” 
proteins in vitro or to create new expression systems for the production of a particular 
protein without compromising host survival? Over the last 30 years, theoretical and 
experimental methods have been extensively applied to study the folding of small, rapidly 
folding domains. However, delineating the folding mechanism of larger, slower folding 
proteins poses an enormous experimental challenge, due to the complex structure of these 
proteins that are stabilized by long-range interactions. Understanding their folding within 
the constraints of the chaperonin nanocage may allow us to evolve enzymes of therapeutic 
interest with the use of the chaperonin system. For example, variants of GroEL described in 
this study, such as GroEL∆C with a larger cavity size, may expand the spectrum of proteins 
that can utilize the chaperonin to substrates greater than 50 kDa. GroEL variants with 
smaller cavity size may be used to improve the folding rate of other proteins.  
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7.2.    Abbreviations 
ADP  adenosine 5'-diphosphate 
Amp ampicillin 
AMP-PNP Adenosine 5′-(β,γ-imido)triphosphate tetralithium salt 
APS ammonium peroxodisulfate 
ATP adenosine 5'-triphosphate 
BSA albumin bovine serum 
CAM  chloramphenicol 
CDTA trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid 
DNA deoxyribonucleic acid 
DnaJ bacterial Hsp40 chaperone 
DnaK bacterial Hsp70 chaperone 
DTT  dithiothreitol 
E. coli  Escherichia coli     
EDTA ethylenediaminetetraacetic acid 
g acceleration of gravity, 9.81 m/s2 
GdnHCl guanidinium hydrochloride 
GFP Green fluorescent protein 
GroEL bacterial Hsp60 chaperonin 
GroES bacterial Hsp10 cochaperonin 
GrpE bacterial nucleotide exchange factor of DnaK 
h hour 
IPTG isopropyl-β-D-1-thiogalactopyranoside 
Kan kanamycin 
LB Luria Bertani 
MBP Maltose binding protein 
METF 5,10-methylenetetrahydrofolate reductase 
MOPS 3-(N-morpholino)propanesulfonic acid 
NAC nascent chain-associate complex 
NADPH β-nicotinamide adenine dinucleotide 2'-phosphate 
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OAc acetate 
OD optical density 
PAGE PolyAcrylamide Gel Electrophoresis 
PCR Polymerase Chain Reaction 
PDB Protein Data Bank. Repository for processing and distribution 
of 3-D structure data of proteins and nucleic acids. 
http://www.rcsb.org/pdb/ 
PPIase prolyl- cis/trans isomerase 
RAC ribosome-associate complex 
S. cerevisiae Saccharomyces cerevisiae 
SDS sodiumdodecylsulfate 
TEMED N,N,N',N'-tetramethylethylenediamine 
TF trigger factor 
TRiC Tailless complex polypeptide ring complex 
Tris HCl tris(hydroxymethyl)aminomethane hydrochloride 
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